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In 2016, over 11 million people misused prescription opioids and the economic 
costs were estimated to be over $500 billion. In the same year, opioids killed 42,000 
people, which was more than any year on record. These data highlight the need to reduce 
the harm caused to individuals, families, communities, and the nation. One element of a 
more comprehensive national strategy is increasing awareness among citizens, physicians 
and policy makers. Given its widespread reach YouTube can be very helpful. There is a 
large literature on the opiate epidemic, but no published studies describing the sources or 
content of YouTube videos on the opiate epidemic were identified. This study was, 
therefore, intended to help fill this gap in current knowledge.  
YouTube was searched using two key terms, “opiate addiction” and “opioids.” 
The results were sorted by number of views, and the URL, title, and number of views 
were saved for videos with a minimum of 1,500 views. Videos were then screened for the 
inclusion and exclusion criteria. The remaining sample comprised 309 videos.  
		
Collectively, these 309 videos were viewed 44,693,887 times. The results 
revealed the sources that were most viewed and the nature of content that was and was 
not likely to be covered. The two main sources of videos were Internet Based and 
Television news/Entertainment. Compared with videos with health professions as the 
main speaker, those featuring consumers garnered almost 10 times as many cumulative 
views (30.35%versus 3.24%). Government organizations uploaded 11 videos (< 4%), 
collectively garnering 343,983 views (less than 1% of cumulative views). 
YouTube represents an important opportunity for health promotion and disease 
prevention regarding the opiate epidemic. However, improved understanding about ways 
to communicate accurate and useful information in ways that attract viewers is needed. 
Recommendations for research, policy and practice are presented relevant to how 
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Over the past two decades, prescription opioid misuse, opioid use disorder and 
overdose grew in United States into epidemic proportions (Cochran, Field, & Lawson, 
2015). Prescription opioids overdose deaths surpassed all other drug-related deaths 
(Madras, 2017). As a result, the prevalence of prescription opioid dependency, abuse and 
overdose gained attention among the public, policy makers and the clinical community 
(Jones, 2016).  
The opioid epidemic, involving both prescription opioids and heroin, received 
initial media attention in Maine and Ohio in 2000 (Whelan & Asbridge, 2013). Since then 
it has already killed more people than crack cocaine in the 1980’s and heroin in the 
1970’s combined (Netherland & Hansen, 2016). In 2015, opioids killed 33 000 people 
and almost half of these fatalities were caused by prescription opioid (McIver, 2017). 
Physicians’ prescriptions became a major source of opioids as its sales rose 300% in the 
past 20 years. The U.S. Department of Health and Human Services [HHS] in 1992 and 
the Joint Commission on Accreditation of Hospitals in 2001 introduced the emphasis of 





Prevention, 2016). Despite missing scientific evidence that chronic pain can be safely and 
effectively treated by opioids, during the past two decades 50% of all opioid sales were 
designated for chronic non-cancer pain (Madras, 2017).  
In 2011, all narcotic analgesic prescriptions exceeded 252 million. Even though 
the Centers for Disease Control and Prevention declared a prescription opioid overdose 
epidemic in 2011, opioid prescriptions increased and reached 255 million in 2012 
(Sweeny, 2016b). Since 2012, the overall rate of opioid prescriptions declined and in 
2016, it decreased to the lowest it has been in more than 10 years - to over 214 million 
total opioid prescriptions (Centers for Disease Control and Prevention [CDC], 2017l). 
Prescribing rates are highest among providers specializing in pain medicine 
(49%), surgery (37%), and physical medicine/rehabilitation (36%). Primary care 
providers account for about half of opioid pain relievers dispensed (CDC, 2017g). As 
high prescribing rates continue to prevail across the country (CDC, 2017l), prescription 
opioids continue to be a primary cause of opioid-related deaths (Madras, 2017).  
Because healthcare professionals prescribe opioids, users sometimes falsely 
believe that such substances are safer than illegal drugs (Foggers & McGuinness, 2014). 
The vast amount of prescription opioids has been associated with a concomitant increase 
in non-medical prescription opioid use. In the past few years, regulatory controls have 
reduced availability of prescription opioids (CDC, 2017k), and many insurance 
companies have encouraged access to pain medication that has a lower risk of addiction 





When prescription opioids became less accessible, or when individuals could not 
afford to buy them at the “pill mills” (Penm et al., 2017), those who were dependent often 
turned to the black market (Foggers & McGuiness, 2014). In underground markets, they 
were introduced to low-cost, more potent, widely available options, including heroin 
(Jones, 2016) and fentanyl analogs (Madras, 2017).  
Prescription opioids can be a significant component for treatment of acute pain, 
cancer pain and for palliative care management (Martins, Santaella-Tenorio, Marshall, 
Maldonado, & Cerdá, 2015). However, they are not the first line of the treatment for 
chronic pain (Lembke, Humphreys, & Newmark, 2016). While changing prescribing 
practices would be a very meaningful step in the right direction, this alone will not fully 
address the current prescription opioid epidemic. In addition, major improvements are 
needed in the prevention of prescription opioid misuse, and in the treatment of both 







Officially launched in May 2005, YouTube has today over 1 billion users with 
one billion hours watched daily. People in 88 countries speaking 76 languages (YouTube, 
2017) take some form of social action on YouTube (e.g. likes, shares, and comments) 
every week (Syed-Abdul et al., 2013). In a recent survey of teenagers, about 85% chose 
YouTube as their preferred source for video content (Romer, Jamieson, Jamieson, Jones, 





to increase awareness and interest in disease prevention and health promotion in general 
(Basch, Fung, Berdnik, & Basch, 2016) and, more specifically with respect to opioid 
misuse, overdose prevention and alternative therapies for chronic pain. Because stigma 
significantly impacts substance users as well as their families, YouTube could be the first 
communication medium where individuals or families affected by opioid misuse or 







While there is a large and growing literature on prescription opioid dependency, 
misuse and overdose, we did not identify any published studies investigating the content, 
sources and characteristics of YouTube videos related to misuse of prescription opioids.  
Improving understanding about this topic is well aligned with objectives specified in 
Healthy People 2020, a blueprint used by the federal government, states, communities, 
and many other public and private sector agencies to guide health promotion and disease 
prevention efforts for all people in the United States (U.S. Department of Health and 
Human Services [HHS], 2016b). Healthy People 2020 includes the topic of Substance 
Abuse and one of its objectives is to reduce nonmedical use of prescription drugs. In 
2008, 4.8 % of persons aged 12 years and over reported nonmedical use of pain relievers. 
This measure is targeted to be decreased by 2020 (Healthy People, 2018).  
This study has a short-term goal to describe the most viewed videos on YouTube 





date uploaded, and content. The content analysis will examine the extent to which widely 
viewed videos are consistent with well-established facts and guidelines from authoritative 
sources. The longer-term agenda is to improve understanding about ways to reach large 
audiences of people with accurate and helpful information related to prevention and 
treatment of prescription opioid misuse and opioid use disorder.  
The Specific Aims of the Study include the following  
1. To examine the most widely viewed YouTube videos on the topic of 
prescription opiate addiction with respect to source, speaker, format, number of views, 
length, and date of upload.  
2. To examine the most widely viewed YouTube videos on the topics of 
prescription opiate addiction with respect to content, including background information 
about the opioid epidemic; signs and symptoms of prescription opioid misuse; risk 
factors; first use; populations at risk for misuse; opioid dependency withdrawal 
symptoms; information on opioid use disorder and overdose and its reversal; stigma; 
treatment of opioid use disorder; alternative options for treatment of chronic pain; 
prevention strategies for individuals, providers and communities; information on locating 
a treatment or help; consequences; and barriers preventing discontinuation of prescription 
opioid misuse. 
3. To explore the extent to which content covered in the videos varies when they 
are categorized by source.  
4. To explore the extent to which content of videos varies when they are classified 









YouTube is viewed by millions of people daily and content of videos may have 
significant impact on the viewer. There is a large literature on the opioid epidemic, 
however, no published studies describing the sources or content of YouTube videos on 
the topic were identified. This study will, therefore, help fill gaps in current knowledge 
by determining the sources and content of YouTube videos on the prescription opioid 
epidemic. Content presented in the most widely viewed videos will be coded and 
analyzed to assess the extent to which material presented is aligned with facts from 
agencies such as Centers for Disease Control and Prevention, National Institute on Drug 
Abuse, or Substance Abuse and Mental Health Services Administration. 
Because of its widespread reach, YouTube is an important channel for 
communicating with the public about disease prevention and health promotion. Many 
people may turn to this medium because of its convenience, because its use does not 
require a high level of reading literacy, and because of stigma associated with addiction. 
For these reasons, affected individuals and families may be more inclined to seek 
information from this kind of source versus speaking with a health professional. In 
addition, in some areas such as rural areas, which have been greatly affected by the opiate 
epidemic, the health professionals’ reception of the people struggling with opioid use 
disorder may be “cold at best” (McIver, 2017, p. 478). Description of the content in 
YouTube videos will help to determine if the information presented is consistent with 





most widely viewed, insight about ways to produce videos that appeal to individuals 
suffering from prescription opioid dependency, their family members and the public in 
general may be identified.  
Given the extent and seriousness of the opioid epidemic, there is a great need for 
approaches to increase awareness and promote behavior change to prevent misuse of 
prescription opioids. Taming the opioid epidemic will require changes beyond health care 
(McIver, 2017). For example, West, Lister, Perry, Church and Vance (2014) suggested 
findings from research using YouTube videos on health-related issues could inform 
organizations that desire to create effective public service announcements and videos. 
Thus, this research is a first step in a longer-term agenda to help educate the public and 























This literature review begins by providing background of the prescription opioid 
epidemic, followed by the personal factors and social determinants that are associated 
with dependency on prescription opioids, and disparities that occur in various 
demographic subgroups of those who become addicted. Then selected literature regarding 
prevention strategies and treatment efforts is outlined, including the assessment of the 
YouTube platform for disease prevention and health promotion, particularly as it relates 
to prescription opioid dependency.  
 
 




Prescription opioid is a semi-synthetic medicine that is derived from Opium 
Poppy (latin Papaver somniferum). Even though it is not known how the medicinal 
effects of Opium Poppy were first discovered, they were known in Mesopotamia since at 
least 3000 BC (Blakemore & White, 2002; Brook, Bennett, & Desai, 2017). Despite 





created dependence, pain medications derived or semi-synthetized from opium were 
promoted to contemporary society as non-addictive, which largely contributed to today’s 
opioid epidemic. 
 Opium was called the drug of gods (Ling, 2017). Its effects were depicted in the 
statues of several gods holding or wearing poppy plants, including, Minoan, goddess of 
the narcotics; Hypnos, god of sleep; Nyz, god of night; and Thanatos, god of 
death (Kritikos & Papadaki, 1967). Opium use became widespread in the Middle Ages 
through the Renaissance periods with wide use of opium for medicinal as well as 
recreational purposes. Many famous historical figures, including Benjamin Franklin, 
Samuel Johnson, Napoleon and Edgar Allan Poe, were known for use and addiction to 
opium (Brook et al., 2017). In 1806, Sertürner isolated the active molecule of opium in 
the pure form and named the white crystalline powder morphinum, after Morpheus, the 
Greek god of dreams (Blakemore & White, 2002). About 70 years later, researchers 
Heinrich Dreser and Friedrich Bayer discovered diacetylmorphine (diamorphine), which 
was marketed to Germans as a cough remedy under the brand name Heroin (derived from 
the German word for heroic). Diacetylmorphine is metabolized to morphine in the body, 
but it rapidly crosses the blood-brain barrier and creates a euphoric rush. This property 
makes the drug especially addictive (Blakemore & White, 2002).  
 In the 19th century, clinicians discouraged the use of pain remedies. They argued 
that pain was a sign of physical strength vital to the healing process, and it acquired 
spiritual benefit (Lembke, 2012). Pain was also viewed as an existential experience and 





Narcotic Act in 1914 physicians were aware that opioids could be addictive; therefore, 
they used them cautiously especially in the treatment of the chronic pain (Tompkins et 
al., 2017).  
In the past few decades, views of pain have shifted (Lembke, 2012). The 
“opiophobic” 1980s (Webster et al., 2017) were replaced by skyrocketing rates of 
prescriptions of OxyContin sold by Purdue Pharma in late 1990s (Quinones, 2015). 
Modern-day opioids are no longer offered only to cancer and palliative care patients, but 
have been and continue to be widely prescribed to outpatients who suffer from acute and 
chronic pain.  
In 1995, the American Pain Society supported a campaign to consider pain as the 
‘Fifth Vital Sign’. They believed pain, a subjective unpleasant sensory and emotional 
experience, was undertreated (Tompkins et al., 2017). In 2000, the Joint Commission on 
Accreditation of Hospitals released Standards on Pain Management where they 
acknowledged the right of the patients to proper assessment of pain (Glod, 2017).  
In patient satisfaction surveys, hospitals have begun to link measures of quality 
services to questions of pain (Sweeny, 2016a). Clinicians who were not keen on 
prescribing the opioids or who suspected misuse received poor ratings, which often 
affected their compensation (Lembke, 2012). In 2015, the Center for Medicaid and 
Medicare recognized the impact of questions about pain and uncoupled them with the 
surveys (Sweeny, 2016b).  
Many practitioners were not taught the necessary skills to integrate risk reduction 





Gordon, 2016, p. 1). Webster et al. (2017) investigated studies related to training of 
medical students and found that opioid addiction education was lacking; instead medical 
schools were offering lectures supporting pharmaceutical companies, and educators were 
downplaying the harmful effects of opioids (Webster et al., 2017). Their review also 
suggested that medical education barely touched the non-pharmacological approaches for 
managing chronic pain (Webster et al., 2017).  
Pharmaceutical companies downplayed the addictive properties of new opioid 
medicines based on a letter in the New England Journal of Medicine that was taken out of 
context (Quinones, 2015). In 1980, a brief paragraph in the New England Journal of 
Medicine stated, “despite the widespread use of narcotics in hospitals, development of 
addiction is rare” (Porter & Jick, 1980, p. 123; Quinones, 2015). The statement was based 
on a retrospective study in which the sample consisted solely of hospitalized patients. The 
claim that the new opioid medications were non-addictive (Schwartz, 2017) was taken 
out of context and was heavily cited and used to justify the safety of prescribing opioids 
to outpatients suffering from chronic pain (Tompkins et al., 2017). Pain specialists 
offered physicians attending conferences sponsored by pharmaceutical companies biased 
“evidence.” Prescription opioids became a magic answer and a quick fix to pain 
management (Sweeny, 2016c). Even though many physicians had an honest goal helping 
people in pain, the missing information about opioids’ dark side contributed to over 
prescribing and, to a great extent, caused the current opiate epidemic (Sweeny, 2016c).  
The prevalence of treating non-acute pain with opioids by primary care physicians 





companies implemented marketing strategies involving personal visits to doctors by 
pharmaceutical representatives, free give away trips for continuing education, and free 
coupons and samples of opioids (Quinones, 2015). Sixty percent of the abused opioids 
were often obtained from physicians; who were sometimes aware that their patients were 
misusing or diverting the medication (Lembke, 2012); and more than half of the patients 
with chronic pain who used opioid therapy for 90 days were still receiving opioids four 
years later (Martin et al., 2011). As many as 1 in 4 people who received prescription 
opioids for treatment of long term noncancerous pain in primary care settings struggles 
with addiction (CDC, 2017b). Access to opioids caused a corresponding upsurge in 
misuse and abuse (Wachholtz, Foster, & Cheatle, 2015) and gave roots to the 
contemporary opioid epidemic where fatal opioid overdoses have escalated 
exponentially, resulting in more than 16,000 deaths per year (Barth, Guille, McCauley, & 
Brady, 2017).  
The revolution in pain management opened the door to a massive supply of 
opioids, which affected many areas of the U.S. as a modern plague (Sweeny, 2016c, 
Lembke et al., 2016). In some localities, opioid pills were used to trade for goods and 
services. A Medicaid card became a ‘gold card’ with which people could obtain pills 
worth thousands of dollars. As a result, millions of lives were ruined (Sweeny, 2016c).  
On one hand, it is a velvet opioid epidemic without the underground violence typically 
associated with illicit drugs such as crack (Sweeny, 2016c). On the other hand, it is the 






Geographic and Economic Impact 
 
 
Prescription opioid misuse and opioid use disorder did not only become a major 
public health problem, but it developed into a significant economic burden for the United 
States and other developed nations (Worley, Shoptaw, Bickel, & Ling, 2015). It is 
estimated that between 26.4 million and 36 million people abuse opioids worldwide, 
including an estimated 2.1 million people in the United States (National Institute on Drug 
Abuse [NIDA], 2014). While the U.S. accounts for about a quarter of the world’s drug-
related deaths (Wen, Behrle, & Tsai, 2017), prescription opioid abuse and dependency is 
a growing problem in other countries such as Australia and Canada (Martins et al., 2017).  
In Canada, nonmedical use of prescription opioids is more common in adolescents 
than in adults and use among adolescents is higher than in pertinent U.S. comparisons 
(Fisher et al., 2013). In 2015, the number of opioids prescribed in the U.S. was nearly 4 
times higher than in Europe (Schuchat, Houry, & Guy, 2017). The International Narcotics 
Board reported that in 2009 U.S. demand for hydrocodone was about 27.4 million grams 
per year compared to 3,237 grams for Britain, France, Germany, and Italy combined. In 
2012, pharmaceutical companies produced more than 75 tons of Oxycodone of which 
more than 80% was used in U.S. (Laxmaiah Manchikanti et al., 2012).  
In the U.S., a statistically significant increase in opioid deaths between 2014 and 
2015 occurred in Connecticut, Florida, Illinois, Kentucky, Louisiana, Maine, Maryland, 
Massachusetts, Michigan, New Hampshire, New Jersey, New York, North Carolina, 





2015; Schwartz, 2017). According to the CDC (2017g), the highest prescribing state is 
Alabama, where health providers wrote almost three times as many prescriptions per 
person compared with those in the lowest prescribing state, Hawaii.  
From 2011 to 2013, the total economic burden of the prescription opioid epidemic 
increased from an estimated $55 billion (Jones, 2016) to an estimated $78.5 billion 
(Florence, Zhou, Lue, & Hu, 2016). These costs include treatment, criminal justice, and 
loss of productivity. The total economic burden, however, does not account for the 
reduction of quality of life of prescription opioid dependents, or the pain and suffering of 
their family members (Florence et al., 2016). Diagnosis code ICD-9 for opioid abuse and 
dependence does not distinguish between heroin and prescription pills, which may create 
a bias in these estimates. However, based on recently reported U.S. data, 1.9 million 
people are affected by prescription opioid abuse or dependence and 517,000 by addiction 
to heroin (Florence et al., 2016).  
 
Characteristics of Prescription Opioids 
 
 
Prescription opioids are man-made drugs produced to treat the pain. CDC (2017a) 
recognizes four categories of opioids. The first involves the natural opioid analgesics 
such as morphine and codeine (called opiates) and semi-synthetic opioid analgesics as 
Oxycodone (OxyContin®), hydrocodone (Vicodin®), oxymorphone. The second category 
is Methadone, a synthetic opioid. Next category includes synthetic opioid analgesics as 





present the fourth category of opioids (CDC, 2017a; Dasgupta et al., 2013).  
Opioid use can cause decreased blood pressure and heart rate, and drowsiness; at 
high doses, it can cause sedation and respiratory depression. It can also cause euphoria, 
increase tolerance to distress and pain, and produce hedonic effects (Wachholtz et al., 
2015, p. 3). Side effects of opioids include constipation, nausea, sleepiness, confusion, 
depression, decreased testosterone, itching and sweating. The CDC (2017h) states that 
even when taken as directed, the use of these substances will cause tolerance and has a 
high risk for habituation (Sweeny, 2016c). Research has shown that those who use 
opioids for a prolonged time, even as prescribed by a physician, are at high risk of 
developing physical dependency and opioid use disorder (CDC, 2017b; Lembke et al., 
2016). The use of too many opioids, alone or with other substances, can cause sleepiness, 
and confusion (Substance Abuse and mental Health Services Administration [SAMHSA], 
2015b) or can lead to respiratory depression leading to death (CDC, 2017h).  
Prescription and illegally manufactured opioids are chemically similar and affect 
two systems in the human brain. In addition to their effects on pain receptors, they also 
interact with the opioid receptors and produce euphoria, which significantly increases 
their potential for misuse (NIDA, 2017). Opioids increase the amount of dopamine, the 
neurotransmitter that causes intense pleasure in the limbic reward system, which can 
drive users to seek out the drug repeatedly (NIDA, 2014). When drugs of abuse come in 
and “hijack” the same circuit, people learn to use drugs in the same way. If the drug is 
used again and again, neurons begin to reduce the number of dopamine receptors or make 





depressed and is unable to enjoy things that once brought pleasure. Drugs are needed just 
to bring dopamine levels up to normal, and more of the drug is needed to create a 




Misuse, Dependence and Opioid Use Disorder 
 
 
Prescription opioid misuse and abuse includes intentional or unintentional use 1) 
without a prescription, 2) in a way other than as prescribed (Han et al., 2017) or 3) for the 
feeling it triggers (SAMSHA, 2017; West et al., 2014). People who are dependent on or 
who abuse prescription opioids often change the way they take it (e.g., snorting or 
injecting) to intensify the effect (SAMHSA, 2016). Co-abuse of opioids and other drugs 
such as benzodiazepines (Hwang et al., 2014), tranquilizers or stimulants (Jones, 2016) is 
also common. From 2002-2014 the use of opioids with sedatives contributed to nearly 
one third of all opioid deaths (Hwang et al., 2014). The use of alcohol over the past year, 
as well as marijuana and heroin use was significantly associated with opioid analgesic 
abuse (Jones, 2016).  
Physical dependency and withdrawal symptoms are often present in people that 
use or misuse opioids or have an opioid use disorder. Physically dependent individuals 
rely on the opioid to maintain physiological homeostasis. When the drug is discontinued, 
the person will experience severe adverse physiological and mental symptoms of 
withdrawal. Such symptoms include nausea and vomiting, cold and hot flashes, anxiety, 





Lengthened opioid exposure also heightens pain sensitivity, known as 
hyperalgesia (Wachholtz et al., 2015). Individuals with opioid-induced hyperalgesia may 
experience pain in the same anatomic location under treatment, and they increase their 
dosage to improve ability to tolerate such pain. Individuals with opioid-induced 
hyperalgesia will also experience pain in other locations, which would be improved by 
decrease in opioid dose.  
It is important to note that individuals will not necessarily be diagnosed with 
addiction if they experience tolerance, physical dependency and withdrawals, while using 
opioids as prescribed. The Diagnostic and Statistical Manual of Mental Illness 5th Edition 
(DSM-5) excludes physiological tolerance and detrimental medical effects from 
diagnosing opioid use disorder (Lembke et al., 2016). Opioid use disorder (addiction) is 
described by DSM-5 by the presence of the three “C” s: control loss, compulsion, and 
continuous use. Thus, to be diagnosed with opioid use disorder, an individual has to 
demonstrate damaging behaviors involving using larger numbers of pills than prescribed, 
seeking early refills, or doctor shopping. Such individuals will also compulsively use 
every available resource to attain and use the drug and continue to use the opioid 
regardless of the harmful consequences. Individuals who experience withdrawals, 
physical tolerance and dependency while using opioids as prescribed thus do not exhibit 
the characteristics of addiction (Lembke et al., 2016, p. 983; Sweeny, 2016; Wachholtz et 








Shift to Heroin 
 
 
Substantial evidence has shown that individuals with previous nonmedical use of 
prescription opioids are at higher risk of heroin use (Martins et al., 2015). In the raging 
opioid epidemic, several recent measures have been taken to cut the excess supply of 
prescription opioids that are diverted for non-medical use.  
In 2010, Oxycodone, which is one of the widely prescribed prescription opioid 
analgesics, was reformulated so it could not be dissolved in water (Foggers & 
McGuiness, 2014). This prevented it from being dissolved and injected. The National All 
Schedules Prescription Electronic Reporting Act and establishment of state-run 
monitoring system in 49 states decreased the supply of medication. The Centers for 
Disease Control and Prevention released Guidelines for Prescribing Opioids, which 
advise careful prescribing of these substances (CDC, 2017d). However, these measures 
may have the unintended consequence of sending prescription opioid users to a black 
market where they were introduced to a much cheaper, more potent and more widely 
available option with a similar molecule, heroin (Jones, 2016; Martins et al., 2015).  
The addiction to prescription opioids indirectly created markets for heroin within 
communities around U.S. where the heroin market had not existed previously (Quinones, 
2015). Black tar heroin dealers from Jalisco, Mexico, with the “pizza delivery” drug 
marketing model, started infiltrating small towns with heroin that was one fifth the price 





with plentiful visits, Jalisco heroin dealers were visiting their customers with small 
amounts of heroin to make sure they continued using (Sweeny, 2016c).  
The fact, that some dealers sell both illegal drugs and prescription drugs may 
facilitate the gradual intensification of drug use. Those who transfer from prescription 
pills to heroin are usually more likely to be in an advanced stage in their drug use history 
(Martins et al., 2015). Some users may be already injecting the prescription drug at that 
point, so the fear of needles is not an issue anymore (Quinones, 2015).  
The cost of heroin greatly contributes to this shift. Heroin can be purchased for 
$15 to $20 for 100 milligrams. One opioid pill purchased illegally can cost about $20-$30 
(Foggers & McGuiness, 2014), depending on its weight (usually $1 for 1 milligram). 
Thus, with a prescription, an 80-mg tablet will cost about $6, but when sold on the black 
market, the cost will be about $80 (Connecticut Clearing House, 2017).  
Martins et al. (2015) revealed the substantial rise in the yearly rate of heroin use 
between 2002-2005 and 2008-2011 was only seen among non-Hispanic whites that 
reported non-medical use of prescription opioids. The rise in heroin use and prescription 
opioid use among non-Hispanic whites seemed to be parallel. Even more, the rate of 
heroin dependence among heroin users from the 2002-2005 to 2008-2011 did not 
significantly increase. When the general population was used as a denominator, a 
significant rise in the annual rate of heroin abuse and overdoses among non-Hispanic 
whites was observed. These results support the suggestion that non-medical prescription 
opioid use is connected to heroin use and heroin overdoses within this population 









Person Risk Factors 
 
 
Even though much of the research states that opioid use disorder, prescription 
opioid overdoses and deaths can happen to anyone, certain disparities exist. Disparities 
are grounded not only based on sex, age, and racial differences, but also on religion, tribe, 
national origin or refugee status, sexual orientation, and social position (Braverman, 
2006, p. 184). According to the 2014 National Survey on Drug Use and Health, an 
estimated 2.1 million Americans used prescription drugs non-medically for the first time 
within the past year, which averages to approximately 5,750 initiates per day. Fifty-four 
% were females and about 30 % were adolescents (SAMHSA, 2015a). 
Although, on average, more men die from drug use overdoses than women 
(Kozhimannil et al., 2017), the complex risk factors associated with abuse of prescription 
opioids among women are concerning (Hemsing, Greaves, Poole, & Schmidt, 2015, p. 2). 
About 18 women die every day of a prescription opioid analgesic overdose in the U.S. 
Between 1999 and 2010, deaths caused by prescription opioid-related overdose among 
women increased 400% compared with a 237% increase in men (CDC, 2013).  
Biopsychosocial (Clark, Anderson, Clark, & Williams, 1999) and environmental 
determinants drastically contribute to disparities between men and women who misuse 
and overdose on prescription opioids (David & Collins, 2008, p. 175). Women have 





longer time. Different sex hormones may contribute to different perception of pain 
between men and women. Other reasons for long-term opioid use among women involve 
endocrine disruption, infertility, neonatal health risks, increased risk for anxiety and 
depression (Hemsing et al., 2016).  
Increased prescription opioid abuse in women is not necessary solely the result of 
neurological responses (Hemsing et al., 2016, p. 2). David and Collins (2008) suggest 
that social and environmental factors may be more important than genetic ones (p. 175). 
Hemsing et al. (2016, p. 2) state that expression of pain is more acceptable from girls 
than from boys because of the gender role socialization that we are accustomed to since a 
young age. Women are more likely to “experience trauma, gender–based violence and 
psychological effects of trauma” (Hemsing et al., 2016, p. 3). In general, women who 
have experienced trauma, including intimate partner violence and sexual abuse, are more 
likely to suffer unrecognized or hard to treat medical conditions such as physical injuries 
(Hemsing et al., 2016, p. 3).  
Many qualitative studies have shown that women started to misuse prescription 
opioids as an attempt to care for themselves, as this may be the most accessible form of 
self-care (Buer et al., 2016, p. 2). Buer et al. (2016) conducted face-to–face semi-
structured interviews with women in Appalachia who reported that, despite their desire to 
decrease prescription opioid use, they are overwhelmed with the stress and social 
isolation of caretaking work. Especially in rural areas, women indicated that poverty, 
unemployment, lack of affordable health care, lack of mental health care, inaccessibility 





limit their options to decrease use. Others revealed they continue using because it was 
their only means to cope with physical and emotional pain (Buer et al., 2016, pp.7-8). 
This resulted in women being targeted more than men by pharmaceutical marketing, and 
being prescribed higher doses of opioids by physicians. Using prescription opioids to 
cope with traumatic experiences expose women to a higher risk for opioid additive side 
effects and possible overdose (Manubay et al., 2015).  
Over the past 10 years, non-medical use of opioids in pregnancy almost doubled 
(Kozhimannil et al., 2017). The rise in prenatal opioid use poses a substantial public 
health concern, with the health and social risks not only for women, but for the infants 
and families as well. Opioid use during pregnancy is linked to heightened risk of preterm 
birth and neonatal abstinence syndrome. These newborn withdrawals are a large 
contributor to infant mortality. 
Kozhimannil et al. (2017) examined cross-sectional data from 2005 to 2014 from 
the National Survey of Drug Use and Health (NSDUH) of over 8000 women ages 18-44 
and selected women who identified past 30-day non-medical opioid use. The sample was 
asked 10 questions about the source of opioids while they were ensured privacy when 
answering survey questions in their home. Delicate questions were asked confidentially 
via computer with headphones. They separately studied data for the women who reported 
that they were pregnant at the time of the survey. Researchers investigated associations 
between the three most common sources of opioid non-medical use – doctor, friend or 
relative, and dealer – and pregnancy status. Almost half of pregnant women in this 





women reported a friend or relative as source. This suggests the need for targeted policy 
efforts to address opioid use during pregnancy and over the reproductive years 
(Kozhimannil et al., 2017).  
HHS (2016b) states that lack of special treatment programs for adult, pregnant or 
postpartum women as well as low treatment utilization of the existing programs may 
contribute to the discrepancy between men and women in prescription opioid misuse. 
Future research should systematically evaluate the impact of interventions while 
considering the unique aspects of women across age, race, and socioeconomic spectrums 
(HHS, 2016b). Research recognizing gender-based differences (Kozhimannil et al., 2017) 
holds the potential for improving clinical evaluation, tailoring pain management 
strategies, minimizing misuse and improving treatment programs (Manubay et al., 2015). 
Netherland and Hansen (2016) indicate that prescription opioids were initially 
marketed to a predominantly white and prosperous, suburban population. These 
individuals had private health insurance and regular access to primary care physicians. 
Prescription opioids thus entered the universe of drug trade as legal drugs dispensed by 
healthcare practitioners (Netherland & Hansen, 2016). Resulting non-medical use of 
prescription opioids was found to be almost twice as high among whites as Blacks 
(Netherland & Hansen, 2016). As prescription’s opioid overdose deaths in women more 
than quadrupled in the past decades (Han, et al. 2017), death rates especially among 
white and indigenous women have significantly increased. At the same time, opiate 
‘overdose’ death rates among Blacks or Hispanic have decreased (HHS, 2016b). 





Alaskan Native women are at a higher risk for prescription opioid misuse, overdose and 
death in comparison to African American or Hispanic women (HHS, 2016b).  
The U.S. Department of Health and Human Services (HHS, 2016b) proposed that 
middle class white women are more likely to be treated for chronic pain than minority 
women, which contributes to an increase in opioid prescriptions for this group. Other 
studies support that institutional racism (Clark et al., 1999) interlaced with socio-
economic status indicates the high risk of prescription opioid abuse and dependency of 
indigenous women (Netherland & Hansen, 2016). According to the HHS (2016), 
clinicians’ bias contributes to inequality in rates of prescribing opioids such that 
“minorities are being less likely to be prescribed opioids” (p. 16).  
Bias in prescribing pain medication for minorities is plausibly influenced by race, 
moral, and legal inequities that resulted from the crack cocaine epidemic of the 1980s–
1990s. Policy responses to the crack epidemic focused on degrading African-American 
and Latino crack users, while leaving white powder cocaine users relatively unaffected 
(Netherland & Hansen, 2016). Discrimination by prescribers may have contributed to 
racial disparities in opioid prescribing (HHS, 2016b).  
Disparities also exist with respect to age. Adults aged 40 years and older are more 
likely to use prescription opioids than adults aged 2039 (CDC, 2017g). But, older adults 
are at higher risk for medication misuse than the general population because of their high 
rates of pain, sleep disorders/insomnia, and anxiety. Their possible cognitive decline 





Just as opioid prescriptions have increased for adults, prescription sales in the 
United States since 1994 doubled for adolescents (Foggers & McGuiness, 2014). The rise 
of opioid prescriptions has been linked to increase in non-medical use among youth. 
Additionally, initial prescription opioid misuse occurring at an early age, has been linked 
to heroin use in late adolescence (Sharp, Estrada, Elio, Prendergast, & Carpenter, 2017). 
On a typical day, 74 adolescents aged 12-to-17 visited an emergency department because 
of prescription or nonprescription pain relievers (SAMHSA, 2015c). Among adolescent 
patients who were hospitalized due to trauma, 12.5% were still taking opioids one year 
after admittance (Pattinson-Sharp, Estrada, Elio, Prendergast, & Carpenter, 2017). 
Adolescents may start using prescription opioids by legitimate prescription, for 
example due to a sports injury (Veliz, Boyd, & McCabe, 2013). Miech, Johnson, 
O’Malley, Keyes and Heard (2015) state that legitimate use of opioid analgesic before 
finishing high school significantly predicts risk of future opioid misuse after high school. 
Surprisingly, this association is linked to individuals who had little to no history of drug 
use and they strongly disapproved use of illegal drugs. Adolescents may also get 
prescription opioids from friends and family (Foggers & McGuiness, 2014), or at the 
‘Pharming’ parties (Zosel et al., 2013). Forty-seven percent of adolescents that medically 
misused prescription opioids were motivated exclusively by pain relief, and 30% of 
nonmedical users were driven by other motives, such as ‘to get high’ (McCabe, West, & 
Boyd, 2013).  
Physiologically, the human brain is vulnerable to addictive chemical substances, 





brain is not fully developed. Substances of abuse act by altering neurotransmission in the 
brain; thus, prescription opioid use may have unfavorable and long-term consequences on 
the developing brain (Wu, Blazer, Li, & Woody, 2011). Because of its effects on opioid 
receptors that trigger feelings of euphoria and stimulate brain rewards system (Foggers & 
McGuiness, 2014, p. 18) they acquire high misuse potential (SAMHSA, 2015c). In order 
to re-create the feelings caused by pain medication, adolescents repeatedly engage in 
misuse. Since opioids were prescribed by a physician, adolescents often falsely believed 
that opioid analgesics were safer than other illegal substances (Wu et al., 2011; Foggers 
& McGuiness, 2014; Ford, Sacra, & Yohros, 2017).  
According to Wu et al. (2011), it seems that only when adolescents develop 
severe or legal problems they come to the attention of adults and seek treatment. Their 
study with a sample of 72 adolescents showed that the majority of the adolescents who 
exhibited symptoms of opioid dependence (83%), abuse (84%), or sub-threshold use 
(91%) did not receive any substance abuse service or treatment. Failure to seek treatment 
could be attributed to fears of stigma and missing knowledge about dangers of 
prescription opioid use (Wu et al., 2011, p. 8).  
 In addition to the demographic factors outlined above, according to the CDC 
(2017a), the following personal risk factors increase susceptibility to prescription opioid 
misuse and abuse: overlapping prescriptions from multiple pharmacies; high daily 
dosage; mental illness or history of substance abuse; living in rural areas or having a low 





with a preadolescent history of sexual abuse and psychiatric comorbidities may also be at 
an increased risk for prescription opioid misuse (Lembke et al., 2016).  
Although pain is reported as a primary reason for use of opioids, those with 
chronic pain reported opioid use more significantly. In a study by Weiss et al. (2014), 
compared with 49% of those without chronic pain, over 80% of those with chronic pain 
stated the pain relief as the main reason for initiating opioid use. Other reasons for misuse 
included getting high, and a small group of the sample in one study reported reasons such 
as anxiety, depression, inability to sleep, or forgetting bad memories. Individuals using 
opioids who did not have chronic pain reported that they used for reasons such as 
boredom, social/interpersonal reasons or cravings (Weiss et al., 2014). 
Consistent with these findings, Han (2017) concluded that 63.4% of American 
adults who misuse prescription opioids reported that the main motivation for their most 
recent misuse was to relieve physical pain. Adults who misuse but do not have an opioid 
use disorder report relief from physical pain as the most common motivation (66.3%), to 
relax (11.2%) and to get high (10.8%). Finding alternative ways to manage pain would 




Social Environmental Risk Factors 
 
 
While much of the research has focused on individual risk factors, social 
environmental risk factors have also played an important role in the opiate epidemic 





health compromising environments (McIver, 2017). During the Modern Healthcare 
briefing on the opioid epidemic in U.S., Nash stated: “It is all about social determinants” 
(McIver, 2017, p. 478). Research suggests that physician prescribing practices, past 
experiences, socio-economic factors, geography, and demography all contribute to 
misuse of prescription opioids (HHS, 2016b).  
According to the CDC (2017h), people living in rural areas or having a low 
income are at higher risk for misuse of prescription opioids. Adults who had lower family 
income, and who did not obtain health insurance or employment are more commonly 
diagnosed with prescription opioid use disorder. For example, people with a family 
income less than $50 000, have higher rates of misuse and use disorder (Han et al., 2017). 
Data from the National Survey on Drug Use and Health, showed that among 71,000 
people aged 12 and older, prescription misuse and abuse occur more in rural areas (Ford 
et al., 2017). One example of the immense impact of overprescribing practices and 
dispensing practices of local pharmacies is a rural town with 392 inhabitants. In a period 
of 24 months, the pharmacy in this town received six million OxyContin pills. To 
consume this number of opioids, each person of this town would have to ingest 31 pills 
every 24 hours (Schwartz, 2017).  
Such a pharmacy presents characteristics of a “pill mill”. It is a term for a clinic or 
pharmacy that prescribes or dispenses without a legitimate purpose and consistently 
violates standard medical practice (Penm et al., 2017). In such situations, it is obvious 
those recipients had overlapping prescriptions, took more pills than prescribed, and that 





practicing in Ohio, who was known to prescribe large amounts of opioids to people 
waiting in the line at his clinic without appropriately diagnosing them (Quinones, 2015).  
Besides physician and pharmacy practices, neighborhood type is another social 
determinant that influences prescription opioid misuse. Ford et al. (2017) used data from 
the National Household Survey on Drug Abuse of 19,430 adolescents aged 12-17 to 
examine neighborhood characteristics and prescription drug misuse, and found that two 
variables were significantly related. Their study revealed that, compared with adolescents 
who lived in urban areas, those living in suburban and rural areas were more likely to 
report prescription drug misuse. They also found that lack of social capital and social 
disorganization were significantly related to prescription opioid misuse. Findings 
regarding social participation revealed an interesting point, namely that adolescents living 
in places with a lower level of social disorganization were less likely to report 
prescription opioid misuse. Social disorganization connects prescription opioid misuse 
and disadvantage of the neighborhood. Further, social capital is very important in 
preventing crime and deviance as it endorses the growth of solid social bonds. The 
analysis revealed that adolescents involved in school or community activities reported 
less prescription drug misuse, but when adjusting for age, race, and gender, participation 
was only significant for respondents who did not use marijuana or other drugs. The desire 
for social acceptance, increased interaction with others (Ford et al., 2017) and peer 
pressure to use opioids helped explain why higher levels of social participation were 





Rural living offers limited access to drug treatment and mental health care, both 
of which affects increased prescription drug misuse. The removal of structural barriers 
(transportation, insurance issues, child care, availability) in rural areas could 
hypothetically increase the use of the substance abuse treatment services (Buer et al., 
2016). The prevention of prescription opioid misuse will require policies and 
interventions that include characteristics of neighborhoods (Ford et al., 2017), and 
includes both downstream and upstream determinants of this problem (Braveman, 








The drug epidemic is not a simple momentary problem; it is a complex, ongoing 
tragedy that is here to stay (DuPont, 2017). To ensure that opioids are prescribed safely 
for those with legitimate pain needs and that the drugs’ benefits outweigh their potential 
harm should be a main interest of everyone involved. The Commission on Social 
Determinants and Health (CSDH) suggests that key roles of the health care system 
include increased focus on disease prevention and health promotion (Marmot, Allen, 
Bell, & Goldblatt, 2011), including education about potential harms of prescription 
opioids. Endorsing laws to educate physicians about prescribing practices is only one part 
of the response to the epidemic. To succeed will require partnerships across the sectors 





communities, researchers, academics and public will have to make major improvements 






According to CDC (2017j), allocating resources and increasing awareness about 
risks of prescription opioids is one of the prevention efforts that could save families from 
the devastation of overdose due to prescription opioid misuse. One role of health 
educators is to disseminate information about the risks and effects of prescription opioids, 
increase awareness about misuse and opioid use disorder, help alleviate stigma 
surrounding substance abuse, and increase the likelihood that people will ask for help. 
Many educational efforts on drug misuse prevention in the past were not successful 
(Lembke et al., 2016).  
The D.A.R.E. program that was widely used in the U.S. in the late 1980s and 
early 1990s was an example of a prevention effort that was not effective. Young people 
were educated on the risks of drugs and how drugs can affect them. The results of the 
program backfired, as it seemingly invited adolescents to try drugs, and their consequent 
drug use actually increased (Caputi & Thomas McLellan, 2017).  
In contrast, a theoretically grounded, evidence-based approach to community 
adolescent substance use prevention in the Icelandic Model had success. By relying on 
global research and policy makers, practitioners and a non-profit research institute 





changes in policies, divorce rates, and youth unemployment, there has been an overall 
decline of adolescent substance use in the ten years since the implementation of this 
project. This showed that cooperation between parents, community, schools and cultural 
traditions are key to effective substance use prevention among adolescents (Sigfusdottir, 
Thorlindson, Kristjanssonm, Roe, & Allegrante, 2008).  
Effective prevention efforts do not teach about the addictive substances, but 
encourage pro-social behaviors even when the drugs are never mentioned. Interventions 
that have been shown to be effective in reducing substance use teach young people 
effective skills such as how to be on time, how to create persuasive argument, and how to 
incorporate ethics and morals into their lives (Sweeny, 2016b). Community-based 
interventions should, however, incorporate knowledge and skills that are directly related 
to prescription opioids. Examples include information on safely disposing of unused 
medications, disseminating awareness on how the Samaritan law related to overdose can 







The rise in prescription opioid misuse, dependency, overdoses and deaths 
prompted creation of federal and state policies to reduce opioid supply and expand 
treatment of opioid use disorder (Madras, 2017). The U.S. Office on National Drug 
Control Policy released a set of recommendations for all states to have efficient 





Schedules Prescription Electronic Reporting Act and authorized grants to establish state-
run monitoring programs in 49 states. Naloxone—a drug that reverses overdose effects—
extension policies have been ratified in 43 states and Washington DC, yet naloxone cost 
remains as a notable barrier to widespread uptake (Barth et al., 2017).  
In 2005, the CDC released Guidelines for Prescribing Opioids (CDC, 2017c); a 
set of evidence-based recommendations on prescribing practices of opioids by primary 
doctors treating chronic pain. Five years later, the U.S. Surgeon General, Dr. Murthy, 
released the first report involving addiction in America—Report on Alcohol, Drugs and 
Health. Long overdue, on October 26th, 2017, the U.S. President declared the opioid crisis 
as a public health emergency. Despite the rhetoric, the President’s budget for fiscal year 
2018 from May 2017 shows $279.7 million increased funding for drug control efforts, 
which is a 1% increase from previous year (Reinl, 2017). At this time, policy changes 
remain insufficient as indicated by the continuing number of opioid deaths (Madras, 
2017, E2).  
In the period between 2006 and 2015 numerous states implemented policies 
intended to decrease prescribing of opioids and overdose deaths. Ohio and Kentucky 
implemented requirements for certification of pain clinics and started to require clinicians 
to review the prescription drug-monitoring program (Schuchat et al., 2017). Despite 
similar actions in other states, national overdose death rates increased due to use of illicit 
opioids.  
Insurance coverage for treatment services related to opioid misuse, dependency 





change. Many alternative treatments for treating pain, such as acupuncture or massages 
are not covered by private insurance or Medicaid, while they are listed as one of the 
options of the first line of treatment for the chronic pain by CDC (2017e).  
Our social system needs to provide alternatives to incarceration of opioid-using 
individuals (HHS, 2016a). For decades, policies have implied that people addicted to 
drugs are morally damaged and lacking in willpower. Society’s responses to drug abuse 
were shaped by those views, treating it as a moral failing rather than health issue. This led 
to an emphasis on punishment rather than prevention and treatment (NIDA, 2014). 
Drug courts are emerging now in many states. As they are tremendously 
progressive, they also could affect a woman’s decision to seek help when they become 
dependent on prescription opioids. For example, potential loss of a child’s custody plays 
a crucial role in the decision to seek help and, therefore, it is important to create social 
systems where women will not have to choose between seeking treatment and losing 
custody of her child(ren).  
One family-centered treatment identified is the Exodus program. Exodus allows 
the entire family to live in the flats within the treatment environment. This program 
reports 80% completion rates and 90% family reunification rates (HHS, 2016a). This 
program has characteristics of cultural humility, and being other-oriented in regard to the 












Ensuring that opioids are prescribed safely should be the main interest of 
everyone involved (Brook et al., 2017), particularly physicians who may inadvertently 
play a major role in the diversion of drugs for non-therapeutic purposes (Cicero & Ellis, 
2017). Changes in medical training that emphasize culturally sensitive education on 
prescription opioids and that recognize that addiction is a disease are indispensable. To 
minimize the environmental obtainability of opioids, it is essential that clinicians adhere 
to prescribing guidelines (Han, 2017). Contemporary experiences of prescription opioid 
misuse should drive medical schools to improve dissemination of knowledge about 
prevention, identifying people at risk, evaluating alternative programs, and referring 
those with opioid use disorders to care and management (Binswanger & Gordon, 2016). 
Insufficient training of physicians about opioids was reflected in recent data that showed 
that 91% of overdosed patients had received a prescription from a physician (Madras, 
2017).  
The significance of empathy in the delivery of high quality care has been 
advocated, but education and training in “compassionate care” has too often been absent 
(Webster et al., 2017, p. 1471). Incorporating cultural competency and cultural humility 
into education and practice is a stepping-stone to better care for people with prescription 
opioid dependency and opioid use disorder. Appropriate gender, race and culture specific 
screenings (Hemsing, Greaves, Poole, & Schmidt, 2016) are significant strategies that 





in prescription opioid misuse. Manubay et al. (2015) stated that understanding sex-
specific clinical profiles might help clinicians identify negative consequences of pain 
syndromes and opioid analgesics early in treatment.  
For example, treatment approaches for women need to be women-centered, 
trauma-informed, and involve harm reduction methods. This will empower women in 
sharing their realities of prescription opioid misuse and dependency (Hemsing et al., 
2016). When clinicians incorporate interventions and approaches that will provide a safe, 
respectful, and nonjudgmental environment, it may enable women to share their stories 
and prompt their healing processes (Hemsing et al., 2016).  
Currently practicing physicians should be required to take a course on addiction, 
just like they had to take a course on pain treatment in 2001 (Lembke, 2012). Since there 
is not an objective measure for the severity of the pain, physicians have to use their 
judgment and knowledge to decide whether opioids are appropriate. It is also very 
challenging for physicians to determine which patients are currently abusing opioids or 
are at risk for abuse. When they conclude that opioids are needed, providing patients with 
information about side effects, withdrawal symptoms, risks for addiction, risks for 
unintentional overdose, and ways to avoid death caused by overdose must be 
standardized in their practice (Barth et al., 2017).  
If clinician suspects that a patient is misusing opioids, they have to confront the 
patient even if it is faster and easier to diagnose pain and prescribe opioids than it is to 
diagnose and treat addiction (Lembke et al., 2016). Cicero, Ellis and Kasper (2017) 





opioids had experience with addictive substances such as alcohol, nicotine and other 
illicit or prescribed drugs prior to receiving their first opioid prescription. Despite 
clinicians’ and patients’ embarrassment, about use of illicit substances or other prescribed 
medications, physicians have to overcome reluctance and ask these sensitive questions 
(Cicero et al., 2017). Incorporation of comprehensive screening for concurrent 
psychiatric conditions, review of patients’ history of substance use, brief interventions 
and referral to treatment would considerably help doctors to limit the opioid supply and 
prevent diversion, misuse and inappropriate prescribing of opioids (Cicero & Ellis, 2017; 




Treatment of Opioid Use Disorder and Chronic Pain 
 
 
The benefits of opioid therapy for acute pain are sustained by multiple clinical 
trials (Lembke et al., 2016), just as are the harms associated with increased opioid 
prescribing for chronic pain in the United States (Bonnie, Kesselheim, & Clark, 2017; 
Han et al., 2017; Lembke, 2016). Recognition of the escalating prevalence of opioid use 
disorder with chronic pain management suggests more consistent use of better options 
(McIver, 2017) for this difficult-to-treat condition (Wachholtz et al., 2015). People 
already addicted to opioids could be successfully treated though Medically Assisted 
Treatment (MAT). A significant step to saving lives was development of Naloxone, a 
medication referred to as “Vitamin N” by emergency department personnel because it 





As opioids are not a first line therapy for chronic pain, following recommended 
alternatives to pain treatments (CDC, 2017e) may actually work better. Some of the 
options include non-opioid pain medicine as ibuprofen, Acetaminophen (Tylenol®) or 
ibuprofen (Advil®); cognitive behavioral therapy; exercising or physical therapy, 
depression medication, corticosteroid injections or therapies such as acupuncture and 
massage (CDC, 2017e).  
It is estimated that 2 million people in the U.S. have opioid use disorder (Schuchat 
et al., 2017), but only 1 in 10 Americans with a substance abuse disorder receives 
treatment (Wen et al., 2017). People that are already suffering with opioid use disorder 
can be effectively treated and enter long-term recovery through a mixture of medication-
assisted treatment (MAT) and psychosocial support. The most successful methods for 
treating opioid use disorder, involve agonist medications (Sigmon et al., 2013) that 
decrease withdrawals and cravings (D’Onofrio, 2015) such as methadone, buprenorphine, 
naltrexone, and their generic forms of FDA approved medications for MAT (Wen et al., 
2017).  
Weiss et al. (2015) examined outcomes over 42 months in the Prescription Opioid 
Addiction Treatment Study (POATS), a multi-site clinical trial lasting up to nine months. 
The study examined different lengths of buprenorphine-naloxone treatment plus standard 
medical management alone or in addition to individual opioid drug counseling. The first 
phase, brief treatment, consisted of 653 participants receiving a 4-week taper. After an 
additional eight weeks, only 7% of participants had successful opioid use outcomes, 





buprenorphine to participants unsuccessful with brief treatment. Out of 252 participants, 
49% showed opioid abstinence in week 12 and ≥ 2 of the 3 previous weeks. They were 
tapered off the buprenorphine during weeks 13-16 and followed for another 8 weeks. 
This sample of 306 was then contacted again after 18 months post randomization. Potter 
et al. (2015) examined long-term outcomes of the POATS. Half of the participants 
completing the month 42 follow-up reported abstinence from opioids without agonist 
therapy, and >75% receiving agonist therapy reported abstinence from other opioids.  
Participants with more severe pain at baseline were more likely to be opioid-
dependent at follow-up. It may be that the severity rather than the simple presence of 
chronic pain has greater prognostic meaning in this population. Study findings suggest 
the importance of access to pharmacotherapy in this population (Weiss et al., 2015; Potter 
et al., 2017). 
D’Onofrio et al. (2015) tested the efficacy of three protocols for treatment of 
opioid dependence: (1) screening and referral, (2) screening, brief intervention and 
referral; and (3) screening, brief intervention, emergency department initiated 
buprenorphine/naloxone treatment and referral to primary care with 10-week follow up. 
The treatment using buprenorphine significantly increased engagement in addiction 
treatment and decreased use of inpatient addiction settings. Although it was a single site 
study with a small sample and it needs replication, results suggest that treatment with 
buprenorphine is more feasible that just referral with or without brief intervention. 
The acute effects of opioid overdose such as respiratory arrest can be reversed 





(FDA) approved medication (Wen et al., 2017). It is safe, effective and non-addictive, 
and it lacks contraindications except for a rare allergic reaction (Green et al., 2017). It 
used to be restricted to emergency departments and first responders, but the 
contemporary epidemic has led to widespread distribution of naloxone (Madras, 2017).  
In 2014, the FDA approved the first naloxone auto-injector (Evzio), which is a single 
injection with the fixed-dose intended to allow individuals without medical training to 
reverse opioid overdose (Gupta, Shah, & Ross, 2016).  
In 2016, CDC endorsed a recommendation that clinicians prescribe naloxone to 
patients taking higher doses of opioids, taking opioids and benzodiazepines, and to 
patients who overdosed in the past or who had history of substance use (Gupta et al., 
2016). Numerous states have implemented efforts that provide various levels of immunity 
from prosecution for doctors who prescribe naloxone to family members or friends of the 
patients. Samaritan laws adopted by 42 U.S. states protect bystanders who possess illegal 
substances when they try to save an individual experiencing an overdose by calling 911 








The over prescription of opioid analgesics goes hand in hand with opioid use 
disorders and the sweeping number of deadly overdoses. Studies show the unpleasant 





associated with this epidemic are often unmentioned in the scientific articles. 
Embarrassment, fears, guilt, loss and grief are common to opioid users or to people who 
care for them. Because of the stigma related to substance abuse, people may need more 
private places to look for information, interact or share their experiences (Binswanger & 
Gordon, 2016).  
YouTube can potentially provide a venue for prescription opioid users who are 
ready to seek information about treatment options or relapse prevention from the privacy 
of their homes. YouTube can also assist caregivers who are unsure of signs and 
symptoms of prescription opioid misuse or who want to find ways to approach the issue. 
In addition to valuable information on the epidemic crisis, these videos could integrate 
the empathy and compassion, while providing information that explains that addiction is 
a brain disease, not a problem of “bad and weak people, unwilling to lead moral lives and 
to control their behavior” (Leshner, 1997, p. 45). Spreading this position on such a 
platform could reach millions of viewers and could help diminish the shame and 
humiliation of addiction. Sharing information about addiction via YouTube could 
improve the quality of life and reduce the unnecessary loss of life (Marmot et al., 2012). 
In contrast, videos can also convey misleading or harmful information. The main 
rationale for this study is that little is known about what information is and is not being 
disseminated in widely viewed videos.  
The key words “YouTube” AND “drugs” and “YouTube” AND “addiction” were 
used to search PubMed on September 25th, 2017 and generated 26 results (a search using 





seven articles were selected for review, including both quantitative and qualitative 
descriptive analyses of YouTube videos regarding drugs and addiction on YouTube. The 
studies focused on education and prevention potential of the YouTube video site, and 
assessed the portrayal of drugs, alcohol and tobacco, on YouTube. No studies that 
specifically addressed opioids or the opiate epidemic were identified.  
The search for the relevant journal articles continued in early 2018 searching 
PubMed and Web of Science databases using the key words “YouTube” AND 
“addiction;” “YouTube” AND “prescription medication;” “YouTube” AND 
“medication;” “YouTube” AND “drugs;” or “YouTube” AND “chronic pain.” Five more 
articles were identified. The literature review also included the dissertation that served as 
an inspiration to the present study. Thirteen articles and the dissertation were used to 
support the potential usefulness of YouTube as a means to share increased awareness and 
interest about the opiate epidemic. A search using YouTube and opiate epidemic, once 
again, yielded no studies.  
To determine whether YouTube could provide a new data source for healthcare 
professionals, Chary et al. (2014) studied data available on social media about 
recreational use of over the counter Dextromethorpan (DXM), a substance that is 
challenging to track otherwise. The primary goal was to determine whether signs and 
symptoms of drugs could be retrieved from YouTube. Substances as DXM are not 
perceived to be a drug of abuse, therefore, they are not systematically investigated as 
illicit drugs. The public health impact of the recreational use of DXM is, therefore, 





Researchers used methods of computational linguistics to excerpt information 
from YouTube comments, and they recreated many of the clinically termed signs and 
symptoms of DXM absorption at various doses. They randomly chose 2000 comments 
from the CouchDB database, removed stop words, and used graph representation of 
English language, WordNet, to group words into clusters. Using the distance between 
clusters, they calculated the similarities of two words as the match of the ratio of the 
shortest path length between two nodules to the width of the graph. The authors found 40 
most frequently occurring words in the body of comments. They found what commonly 
consumed amounts are consequent to what physiological effects. They determined that 
these results correspond with prior reports on DXM. They were able to determine ranges 
of dosage for distinct symptoms and occurrence of death. Some limitations included 
inability to verify YouTube comments, no assessment of physical effects by trained 
clinicians, and that the dosage estimates might be inaccurate. In addition, there was no 
way to control for tone of sarcasm in the comments, and YouTube comments were 
considered in isolation. Despite these limitations, appropriately collected data can 
complement the weaknesses of more traditional data sources.  
The data about the recreational use of DXM obtained through the analysis of 
social media would be difficult to obtain through other means. This type of analysis 
offers an example of an opportunity to increase knowledge about substance abuse. In 
many research situations, users may be reluctant to “admit” characteristics of their use, 
while anonymous social media could be a good source for spotting symptoms otherwise 





other topics in social media, which could enable the automatic extraction of healthcare 
information and complement existing knowledge on substance use.  
Hansen et al. (2016) studied the educational potential of YouTube focusing on 
medication use in pregnancy. In the past 30 years, medication use in pregnancy has 
increased despite the low availability of data about the safety of many of these drugs. A 
survey involving 24 countries indicated that over 80% of women use the Internet to 
inform their decision-making while pregnant (Hansen et al., 2016). A list of the products 
most commonly used in pregnancy was paired with seven pregnancy-related terms and 
searched. The authors used a YouTube Application Programming Interface (API) video 
feed that searches video metadata to detect potential YouTube videos with medication 
and pregnancy-related content. Three researchers abstracted and categorized the content 
information from 651 videos with both pregnancy and medication in the title, which 
resulted in exclusion of 337 videos. Descriptive statistics were used to characterize the 
information abstracted from remaining 314. Results showed that researchers were able to 
systematically extract videos related to safety of medication use in pregnancy. They 
found that the most commonly discussed topics involved birth defects and antidepressant 
medication. Most importantly, the YouTube videos did not adequately reflect knowledge 
about the risks of drugs in pregnancy when they were compared with TERIS (Teratogen 
Information Systems).  
A study conducted by Fixsen and Ridge (2017) researched stories of 
benzodiazepines users regarding withdrawal and recovery that were posted on YouTube 





metaphors and language posted online by the users. For comparative purposes, they 
added autobiographical literature. Out of 14,000 videos found on YouTube, 300 of the 
most popular videos were reviewed. The data were analyzed with attention to phrases and 
linguistics beyond the ordinary language describing user’s experience. The researchers 
examined samples of patient’s writing from every selected site and saved repeated words, 
phrases and large extracts. Words and expressions associated with withdrawal and 
recovery were cross-coded according to category headings. Concepts of recurring themes 
were further discussed. Based on the themes, a second search was conducted. Then the 
final coding scheme was developed and the researchers manually coded data under 
themed headings. The validity of the online accounts of withdrawal was compared with 
autobiographies of benzodiazepine users and clinical texts. Researchers then constructed 
a picture of distress and recovery during withdrawal through the interpretation of the 
expressions and metaphors.  
They identified seven major themes: hell and isolation, anxiety and depression, 
alienation, physical distress, anger and remorse, waves and windows, and heeling and 
renewal. As such processes are difficult and isolating, these videos may be not only 
informative, but be encouraging and supportive for people who turn to online forums and 
seek reassurance and advice. Internet sites also offer the space to celebrate success. The 
researchers were only able to analyze a small portion of all the videos and sites using 
qualitative and interpretative methodology, so the essence of the study was exploratory. 





existing professional models and be of considerable value to practitioners, and warrants 
further exploration.  
Lange, Daniel, Homer, Reed, and Clapp (2010) also undertook a study to 
determine whether YouTube videos offer a potential to observe drug effects in natural 
settings.  The authors studied effects of salvia through observation of publicly posted 
videos. The plant contains the active agent Salvinorin A, which is a potent hallucinogen. 
Researchers were trying to fill in the gap created by a lack of published controlled 
human-laboratory experiments describing salvia’s effects. They found over 3000 videos 
by using the search word “salvia.” Every 4th video was selected until 100 videos were 
obtained. After exclusion of 76 videos that did not include the entire ‘trip’, a second 
search was conducted to create a final sample of 34 videos. Three coders conducted 
observations using an adapted version of the Hallucinogen Rating Scale. Videos were 
split into 30-second intervals starting with the consumption of salvia. Any observed 
effect was coded as present in that interval and was rated for severity on a 5-point scale. 
Dose was calculated by counting the number of hits and the seconds that the smoke was 
held. Variables were examined three ways: 1) duration of effect, 2) duration of severe 
effect and 3) observation of severe effects.  Analysis was conducted by using T-tests and 
Pearson correlations. The authors found that observable effects of salvia can be measured 
(based on dose and administration) and that YouTube videos can be used as a resource 
for behavioral observation research. As the risks linked with Salvia were generally 
unknown, YouTube offered insight about some risk domains that were observed. Effects 





effects may be subtler in laboratory than at home or at a party. YouTube videos thus offer 
the prospect of observing effects of drugs in the natural setting.  
Cavazos-Rehd, Krauss, Sowles, Murphy and Bierut (2017) investigated marijuana 
consumer’s exposure to user- generated online reviews about the drug on YouTube, and 
its potential to influence their purchase of marijuana. This study improved understanding 
about how young adult marijuana users view online reviews, which is important due to 
their potential to shape marijuana purchasing decisions. Cavazos-Rehd et al. (2017) 
searched YouTube to identify marijuana related videos by key words “weed review,” 
“marijuana review,” and “cannabis review.” Using the relevance sorting method, they 
selected the first 40 videos for each of the phrases. After removing duplicates, their 
sample consisted of 83 videos. Twenty videos were reviewed and used to develop a 
codebook, with physical and mental health claims, and physical characteristics of 
marijuana. The research team coded descriptive characteristics of each video, age 
restrictions, overall recommendations made by reviewer about the respective marijuana-
related product, and whether reviewer encouraged follow up social networking for 
viewers. Two research interns coded videos together, and one senior researcher viewed 
and coded videos separately. This resulted in moderate to almost perfect inter-rater 
agreement across all codes. Popularity and engagement of the videos were analyzed using 
descriptive statistics. Distributions of views, comments, likes and dislikes were positively 
skewed, therefore, they were described by the median instead of the mean. 
The second part of the study contained survey about marijuana product reviews 





a proprietary online panel of participants drawn from the over 30 million people who take 
SurveyMonkey surveys. Weights were applied to the survey data so that marginal totals 
matched that of past-month marijuana users aged 18–34 years in the 2014 National 
Survey on Drug Use and Health (NSDUH) on age, gender, and race (Cavazos-Rehd et al., 
2017, p. 3). The sample contained 742 participants, who were asked whether they 
searched the information or reviews about marijuana during the past 30 days, and 
whether they looked for or tried to find information about marijuana. Participants were 
asked about demographic characteristics (e.g., gender, age, race, completed education 
level) and state of residence. Descriptive statistics, logistic regression and multivariable 
logistic regression models were used to analyze the data. The authors found that user-
generated reviews are popular on YouTube, and 1/3 of the sample of young marijuana 
users reported looking for product reviews at least once in the past 30 days. The analysis 
of the content showed that the marijuana product review videos mostly contained positive 
discussions about marijuana. A troublesome finding was that most of the reviewers’ goals 
were to get as high as possible, and there were no educational or warning messages on 
acute effects, impaired cognition, physiological and mental state changes. Understanding 
risks of marijuana use is critical information for young adults who have largest 
prevalence of cannabis use. Further, the majority of the persuasive messages involved 
describing healing properties of marijuana use. One could speculate that the focus on 
positive messages without the negative effects could increase normalization of use. This 
is alarming as many of these videos are readily available and can be watched by underage 





individuals with lower levels of education, which could lead to problematic use 
behaviors. The researchers concluded that prevention efforts should get in gear to 
compensate persuasive videos toward marijuana use.  
Other substances of abuse such as tobacco and alcohol are commonly included 
in television programming and commercials. The study of Cranwell et al. (2015) was the 
first to quantify contemporary exposure of tobacco and alcohol in music videos on 
YouTube. A sample of 110 YouTube videos included records listed in official singles 
charts in the UK. Coders independently examined and coded visual and lyrical content by 
10-second intervals capturing the presence of alcohol or tobacco. Coding categories 
included implied use, paraphernalia, brand appearance, content, and specifically 
electronic cigarette content. Repetitive presence in the same category was coded as a 
single event. If the same appearance crossed into next 10 segments, it was coded as a new 
event. Data were analyzed using basic descriptive statistics. The authors also included 
questions on viewing the 32 most popular songs with high tobacco or alcohol content in a 
national survey of adolescents done by YouGov PLC and the public health non-
governmental organization Action on Smoking and Health. They recruited a random 
sample of 11-18 year olds by email (to them or parents) from a database of people who 
had agreed to be contacted. The sample comprised 2068 adolescents (1064 boys and 1005 
girls), who consented to the survey and then followed a URL link to complete their 
responses on-line. A randomized order of 32 music videos were presented to participants 





seen?’ and ‘Which, if any, of the following music videos have you seen more than once?’ 
(Cranwell et al., 2015, p. 705). All data were analyzed with basic descriptive statistics.  
The study revealed that tobacco (83% of videos) and alcohol (41% of videos) are 
frequently occurring in the content of music videos and are seen by a wide body of young 
people, especially girls. Even though tobacco branding was passively presented, alcohol 
brands were widely recognized and used in lyrics by artists. This study was the first to 
identify emerging use of electronic cigarettes in music videos. The survey showed that 
girls watched and re-watched these videos more often than boys. The researchers 
concluded that use of celebrities to endorse alcohol is a particular problem as they 
promote it via videos directed to youth, and such videos should be restricted and 
controlled more tightly. YouTube’s policy on age should assure that certain content is not 
viewed by underage individuals. Teaching critical thinking to young people could be 
another venue for them to be able to appropriately evaluate the messages depicted by 
such videos.  
Huan, Kornfield and Emery (2016) examined the presence of the e-cigarette 
videos on YouTube. The researcher first created a list of 70 e –cigarettes key words and 
then engaged a ContexMiner, YouTube crawling program that retrieved the videos 
related to e-cigarettes. For each keyword, YouTube crawls were conducted for one year. 
The following characteristics were downloaded to a database: title, description, tags, 
associated channel, posting date, name of uploader account, URL, view count, number of 
comments, number of ratings and average rating. YouTube’s relevance algorithm ranked 





quantity of videos retrieved by crawls, thus additional crawls were conducted where 
videos that matched were chosen depending on the posting date. Through the relevance 
and posting date technique, and after the exclusion of irrelevant videos, the researchers 
build the sample of 28,089 unique videos related to their topic, which were later coded.  
Their analysis showed that YouTube is primarily utilized for promotional and marketing 
purposes (70%). The results also revealed there were over 100 million total views, and a 
high level of user engagement with e-cigarettes content. They discovered there were not 
any age restrictions. These videos were linked to vendors, which may increase 
opportunities for underage purchase. A comparatively small percentage of the videos 
mentioned health (16%) and safety (10%). Future research efforts should focus on 
identifying user’s experiences, which may help to explain whether e-cigarettes are used 
for cigarette cessation and so if they contribute to public health efforts. Further research 
should also examine the content in these videos and how they impact user’s attitudes, 
beliefs, and risk perception regarding e-cigarettes and help inform efforts by policy 
makers and the public health community. 
Paek, Kim and Hove (2010) conducted smoking-related research. The researchers 
examined the extent to which antismoking messages employ message sensation value 
(MSV), kinds of message appeals used (threat, social, humor) and whether these 
characteristics are associated with the viewer responses. The sample of 934 videos was 
created by searching YouTube with four search words: “no smoking,” “antismoking,” 
“smoking prevention,” and smoking cessation.” The videos were coded by using an 





number of cuts were coded by 0 (0-6 cuts), 1, (7-14) or 2 (more than 15). They also 
created a MSV index (0 being low and 13 being high) and coded message appeals as 
either present (1), absent (0), or hard to tell (99). Each of the two trained coders, who 
were blinded to the research questions, coded half of the sample. The inter-coder 
reliability, calculated using Perreault and Leigh’ s Index, averaged 0.90. Many 
antismoking videos were available on YouTube; however, pro-smoking videos were even 
more prevalent. ANCOVA analysis showed that a high level of MSV was linked to high 
number of viewers, ratings and comments. Threat appeals outnumbered social and humor 
appeals, and they were more likely to capture YouTube users’ attention. This finding 
reaffirms why campaign literature has focused on this type of message. Further, when 
high levels of MSV are coupled with humor, this seems to be negatively related to the 
number of viewers. This combination may result in viewers’ disbelief, thereby, 
undermining the seriousness of antismoking cause. The social messages were less 
dominant compared to threat appeals or high levels of MSV. 
One of the study limitations was the cross-sectional design. The researchers 
suggested that further research can determine whether antismoking messages can be 
proven useful in compensating for the large quantity of prosmoking messages on 
YouTube.  
Primack et al. (2016) systematically examined characteristics of YouTube videos 
that involved alcohol brand appearance for brands popular among youth. Video data were 
gathered using the YouTube Application Programming Interface. Researchers used eight 





in the first 20 hits for each search. The sample was sorted by “relevance” and “view 
count” to assess most commonly viewed content as well as content most likely to come 
up. Three experienced researchers individually examined 10 pilot videos and completed 
“in vivo” coding, which included elaboration on descriptive codes based exclusively on 
the audiovisual material. After coding, the researchers met to discuss differences. This 
iterative procedure was sustained for four iterations until a final codebook was 
determined. In order to preserve the integrity of the final data set, pilot training videos 
were included in the final sample. Then two trained coders individually reviewed and 
coded the complete sample of videos. They chose to double code all videos because this 
was feasible and because it improved the final value of the data. Authors developed 21 
codes using available data representing five categories: type, quality, sociodemographic, 
negative and positive associations with alcohol use. Videos were assessed according to 
the specific brand, and characteristics were coded by type. They found that the most 
common videos were advertisements not posted by companies, but uploaded by users. All 
videos portrayed at least one human, mostly men, and they often incorporated humor.  
Not surprisingly, the overall negativity of the videos was very low as the humor 
underlined the positive aspects of alcohol and downplayed the severe consequences. 
These YouTube videos were heavily visited and accessible to underage to youth. Even 
though YouTube has “Age gate” to restrict underage users from viewing inappropriate 
videos, YouTube channels are still highly accessible to youth. Understanding the 
portrayal of specific brands of alcohol associated with solid loyalty may provide 





Primack, Colditz, Pang and Jackson (2015) conducted a study focused on 
portrayal of alcohol intoxication on YouTube, and what factors associated with alcohol 
intoxication were connected to higher view counts. By using five search words, “drunk,” 
buzzed,” “hammered,” “tipsy” and “trashed,” they included the videos in the first two 
pages of search. They used two strategies for each key word: a/ sorting by the 
“relevance” and b/ sorting by the “view count,” which resulted in a pool of 200 videos. 
After the elimination of duplicates and extraneous videos, the resulting sample contained 
70 videos. Two independent researchers coded the entire sample of videos using a 
codebook from existing research. Cohen’s Kappa coefficients were calculated for inter- 
rater reliability, and any disagreements were resolved. The codebook contained 6 
categories, including video characteristics, social demographics, alcohol depiction, 
degree of alcohol use, characteristics associated with alcohol and consequences of 
alcohol (sub-divided into 42 codes). Data analysis were performed using Stata 13.0 and 
included calculation of percentage of videos in each coded category and measurements of 
positivity and engagement. Nonparametric methods were used to determine statistical 
significance. Mann-Whitney U-test was used for binary data and Kruskal – Wallis test 
was used for variables with more than two categories. The results showed that these 
videos were viewed about a third of a billion times. About half of the videos depicted 
females and 90% portrayed males. Almost 90% of videos showed active intoxication and 
only 7% portrayed alcohol dependence indicating withdrawal or tolerance. Researchers 
also found that viewer sentiment was most strongly positive. Nearly half of the videos 





commonly portrayed type of alcohol. This may be concerning as liquor has high levels of 
alcohol and thus higher potential for morbidity and mortality, especially among youth.  
Research has shown that medical students prefer learning resources found online 
compared with textbooks and medical journals (Azer, 2014). Azer (2014) examined the 
quality of education of YouTube videos on pharmacokinetics. Three evaluators searched 
YouTube for videos on the topic using several key words such as “Pharmacokinetics” or 
“Drug absorption.” Included videos had to have clear graphs and illustrations, 
scientifically correct content, clear presentation of the topic and no background noise. 
Numbers of likes, dislikes, comments, viewers, views/per day and video sharing were 
assessed as metrics of user engagement. Statistical analysis included computation of 
relative frequency, means, standard deviations, medians and differences in means were 
assesses using ANOVA. Out of 48 videos in the sample, 30 videos with the total length 
of 351 minutes, created by educators, university professors, or private tutoring body, 
were found to be educationally relevant. The total views of these videos were 12,096 
(65.4%). The other 18 videos totaling 295 minutes were not educationally useful, and 
they were viewed 6,378 times. As data have shown, not all YouTube videos were 
essentially educative mainly due to the fact that anyone can freely upload a video and 
there are no reviewers. The likes of the videos by users did not correlate with the scores 
given by researchers; thus, students have to be aware that not every video with high 
numbers of likes is scientifically robust. However, well-designed videos could have 
potential to widen the students’ learning options, help explain material in textbooks, and 





White, Hayes, White and Hodson (2016) investigated the power of the 
educational videos targeting chronic pain created through the partnership of a public 
hospital in New South Wales and a not-profit primary care organization. The intent was 
to challenge unjustified clinical variations in treating chronic pain and to extend the 
debate on prescribing opioids, three evidence based videos (“Brainman,” “Brainman 
stops his opioids” and “Brainman chooses”) were developed and distributed via 
YouTube. Their aim was to explain how the pain works and simplify a comprehensive 
approach to active treatment. The reasoning behind the videos was to make educational 
resources and treatment options for chronic pain widely available to people. In the initial 
phases of their creation, clinicians wrote down the key messages in less than 10 words. 
Next, through discussion, the key messages were refined. Pain as a lived experience and 
brain interpretation of a threat was the chosen explanatory model, and active self-
management was recommended over passively received medical treatments. A 
professional artist created the simple cartoons for the videos. Repetition of the key 
messages and low literacy language were integrated into the videos, which were narrated 
by a voice artist. The first video was launched in 2011, and the following two were 
uploaded in 2014; and their launches were publicized. The first video was widely viewed, 
and attracted attention by several health care organizations and translated to different 
languages. The second two videos had refined messages and were purposely shorter, both 
being less than 5 minutes, and were also widely viewed. Utilizing social media, 
consistent key messages, and free access contributed to their success. The lack of funding 





Brainman videos on their websites and since it has often been recommended for 
supporting active self-management as an alternative approach in treatment of chronic 
pain.  
The current study was inspired by work of Baquero (2017), which examined most 
viewed YouTube videos related to depression. The study used a cross-sectional design. 
“Depression” was the search term used to find videos, which were sorted by view count, 
and URLs of the most viewed videos were recorded. Videos were then coded by using an 
instrument with demonstrated inter- rater and intra-rater reliability. After exclusion of 
irrelevant videos, the researcher created the sample of 394 most viewed YouTube videos 
that were collectively viewed 155,349,029 times. The videos were coded with respect to 
source, speaker, format, purpose, number of views, length, upload year, and content.  
Descriptive statistics were used to analyze the data and Chi analysis determined 
differences in the content of videos by source.  
Videos uploaded by consumers, internet-based sources, and nongovernmental 
agencies were the three sources that accounted for approximately 85% of the most 
frequently viewed videos and garnered 93% of the total views (n = 144,506,467). Almost 
half of the most widely viewed videos were uploaded by consumers (n = 193, 48.98%), 
and these videos had the highest cumulative view count (74,391,500 views). The results 
show that the content of the videos mainly included signs and symptoms, promotion of 
healthful behaviors and protective factors, risk factors and general information about 
depression. Sleep deprivation was mentioned only in a few videos, but received millions 





viewed. The study’s results also point out that videos with a celebrity as the main 








Eight studies and a dissertation represent a small sample of the hundreds of 
studies indexed by the National Library of Medicine. Nevertheless, some general findings 
seem relevant to the proposed study. First, while YouTube can reach a large audience and 
could distribute factual and reliable content, this does not appear to be the case with 
respect to this topic. Second, YouTube can be used to reach youth with images and 
messages that are inconsistent with health promotion and disease prevention. Third, when 
searching on this topic, the user may be at risk for encountering inaccurate, unreliable and 
possibly harmful information.  














                                            








This chapter describes the methods used in the study. This includes a description 
of the design, identification of search terms, sampling, inclusion and exclusion criteria, 








A cross-sectional study design was used, and observational data was collected at a 
single conceptual point of time from the YouTube platform. Using a computer with a 
clean history, a search on YouTube using key words was conducted, and URLs for ~300 
most viewed videos were copied and saved in a separate file. All videos were viewed 
during January and February to complete the manual coding described below. For each 
video, the following information was coded: source of upload, speaker, format, number 












Identification of the search terms involved piloting using various key words to 
determine which phrase yielded the most relevant videos, most views per video (for the 
top group) and had the highest cumulative views for the top 30, 60 and 100, respectively. 
Based on this pilot work two key words were identified as the most useful for purposes of 
this study because they yielded videos the were relevant to the prescription opioid 
epidemic and yielded videos that were widely viewed.  
 The first search using combinations of various phrases related to prescription 
opioid misuse and opioid epidemic was conducted in March 2017. This helped to 
eliminate phrases that did not yield many videos. These searches were repeated and 
extended in November and December 2017. Prior to each search, history from the 
computer used was deleted. The results were filtered by “view count” to identify the ones 
with the most views. The information, including the number of results, individual views 
the first 30 videos, number of duplicates, and URLs were entered to an Excel sheet. 
Unrelated videos and music videos were excluded. Then, search terms yielding low views 
per each video and low cumulative views were excluded.  
The six search terms with the highest cumulative views for the first 30 videos 
were: “prescription opioids addiction,” “pain pills addiction,” “opiate addiction,” “opiate 
epidemic,” “opioid epidemic,” and “opioids,” were compared in more detail. The number 
of views for each video, URL of the video and cumulative view count for the first most 





found in this process were excluded. After excluding duplicates, the cumulative view 
count for the first 3, 30, 60 and 100 videos as well as the number of views of the 30th, 60th 
and 100th video for each of the six search terms was calculated and logged. Combinations 
of the results using two out of the six key words were compared. This analysis resulted in 








Once the results using those two search terms appeared they were filtered by 
“view count” and videos with a minimum of 1,500 views were selected. This was 
completed on a single day in January 2018. The URLs, titles, date uploaded, and view 
count for each was copied and stored in a separate file. After duplicate videos were 








To qualify for the inclusion in the study, videos had to be in English and their 
primary topic had to be on prescription opioids misuse and opioid use disorder. Videos 
about heroin that involved prescription opioids were included as well. Music videos and 










The instrument used for this study was developed based on an existing instrument 
for coding YouTube videos (Baquero, 2017). The instrument begins with entry of basic 
information relevant to each video, including coder, video identification number (which 
was assigned), date the video was uploaded, date the video was coded, length of video (in 
minutes), number of views, and title of the video. Following this general information, the 
instrument comprises four sections (1) source of upload (2) speaker (3) format (4) and 
content. The variables and values for each of these sections were coded dichotomously 
(i.e., yes or no) indicating the presence or absence in the respective video. The coding 
instrument is included in Appendix A.  
The source of upload for each video was coded into one of the following 
categories Consumers; Professional/provider; Government Agencies; Nongovernmental 
Organizations; Television News/Entertainment; Treatment Center; Celebrity; Internet-
Based; or Other.  “Consumer videos” included videos posted by (A) person with lived 
experience, (B) spouse/partner of the person misusing prescription opioids, (C) parent of 
the person misusing prescription opioids, (D) person without lived experience, but 
sharing information about prescription opioids based on personally knowing someone, 





A consumer video was described as being posted by an individual with no 
obvious professional credentials in medicine, addiction treatment or higher education and 
no established organizational affiliation.  
A “Professional” was categorized as any videos posted by either an individual 
with professional credentials or established organizational affiliations: (A) 
physician/medical doctor, (B) mental health/addiction professional, (C) academic 
professional/professor, (D) emergency room personnel, (E) Judge/Sheriff/Cop or (F) 
Other.  
“Government organization videos” were recognized by the “tag” (.gov), and they 
were defined as videos uploaded by a government agency.  
“Nongovernmental agency videos” were defined as any video uploaded by a 
nongovernmental agency. This was apparent from the “tag” (.org) associated with the 
respective video.   
All videos uploaded by a news-based or entertainment based major television 
network station were considered “Television News/ Entertainment videos.”  
“Celebrity” was defined as a video uploaded by a celebrity. Any video uploaded 
by a treatment center was coded as “Treatment Center.” “Internet-based videos” included 
any video posted by an internet-based site or YouTube channel.  
The speaker category included Consumers, Professionals, Government 
organizations, Non-governmental organizations, Television news/entertainment, 





The categories for coding Format included Documentary, Interview, Talk by 
Professional, TV Talk Show/Discussion panel, Animation, Still images, News report with 
anchor, V-blog, Multiple formats or Other formats. “Documentary” was defined any non-
fictional video that (A) documented aspects of reality on prescription opioids misuse, or 
(B) documented information, instructions and education regarding prescription opioids 
misuse. “Interview” was described as any video with a formal or informal interview 
between two people. “Talk by professional” was any video that was a recording of a 
person giving a professional presentation. “Talk show” was defined as any video with a 
formal or informal talk between more than two people. Videos using cartoons, or 
whiteboard video animations were considered “Animation.” Any videos with only still 
images/photographs were categorized as “Still images.” Videos with the intent to deliver 
news were classified as “News.” Video Blog, “V-Blog” was an online journal or diary. If 
the video was created with more than one format it was considered “Multiple formats.” 
“Other” videos were categorized as any video that did not fit into the coding scheme 
defined above.  
The content categories were formulated based on guidelines, recommendations or 
related advice from the U.S. Centers for Disease Control and Prevention [CDC], the 
National Institute for Drug Abuse [NIDA] and the Substance Abuse and Mental Health 
Administration [SAMHSA]. There were 18 content categories (each with sub-topics) that 
were formulated:  Background of the opioid epidemic, Physical signs and symptoms of 
misuse; Behavioral Signs and Symptoms, Risk factors; Population at Risk, Opioid 





Reversal of prescription opioid overdose; Stigma; Treatment options of opioid use 
disorder; Alternative options for treatment of chronic pain; Prevention strategies for 
providers; Prevention strategies for individuals; Prevention strategies for communities; 
Information on locating the a treatment facility or help; Consequences of an opioid use 
disorder; and Barriers to preventing discontinuation of the misuse. The specific 









The two samples of 30 videos that were not among those most widely viewed 
were coded prior to the beginning of the coding process. The first set of the 30 videos 
were coded by the Researcher. The coding of this sample was repeated in 7 days. The 
second set of 30 videos was coded by the Researcher and by the second rater. All coding 
categories as well as separate content topics within the coding form were included in this 
analysis (i.e., source, format, content, etc.). Cohen’s Kappa coefficients were calculated 
for the first set of 30 videos coded by the Researcher. The coefficients were not sufficient 
so the first round of coding was considered as practice and getting familiar with the 
instrument. The new sample of 30 videos was selected and the coding was once again 
completed on two occasions seven days apart. The entire instrument comprised 259 





“Yes = 1” code. The Kappa test could not be calculated on 85 items because there was no 
variability and all responses were 0. There was perfect agreement for 140 of the variables 
and the remaining coefficients ranged from 0.89-0.93.  
Cohen’s Kappa coefficients were also calculated for the second set of 30 videos 
individually coded by Researcher and the second rater. The Kappa test could not be 
calculated for 74 items because there was no variability. Of the remaining items, 132 had 
a perfect agreement, and the remaining coefficients ranged from 0.8- 0.93. Instances of 
disagreement were discussed in person and reconciled. This process was useful in 
determining which codes needed to be changed, removed or added. After consultation 
with the second rater and the sponsor, 6 items were removed and 8 items were added. 
In the category “Information on opioid use disorder and overdose” one additional 
sub-topic item was added: Harm Reduction strategies. In the category “Alternative 
options for treatment of chronic pain” (C12) one sub-topic item was added: Alternative 
options for chronic pain do not work. In the category “Consequences of opioid use 
disorder” (C17) four sub-topics items were added: Neonatal withdrawal syndrome; If 
they knew the consequences they would never have started start taking pills; Pills destroy 
lives; and the only relationship that mattered was relationship with the pills. Also, two 















The Researcher selected and coded all of the videos. Using a clean history, the 
videos were selected using the two key terms specified above on January 18th, 2018. Once 
the key terms were entered and filtered using the “view count” YouTube filter, the URLs 
from each search term were copied into a separate file to be visited for coding at the later 
time. Because the two search terms were used, the results were reviewed to detect any 
overlapping videos. The URLs that did overlap were marked as duplicates and only one 
URL for the video was kept for coding. As there were over 290,000 results for the search 
term “opioids” and over 47,000 results for the search term “opiate addiction” the arbitrary 
cut point was set to 1500 views or more. All videos were then coded during the months of 
February and early March 2018. To help prevent systematic bias in the order in which the 
videos were coded, the Researcher coded the top 10 videos and then the bottom 10 videos 
within each group alternating groups. The Researcher then proceeded in this way until all 
the videos were coded.  
The whole video segment was used as unit of analysis. First, the video assigned 
ID, title, date of upload, date of coding, length in minutes, and number of views was 
entered. Second, the “source” was identified. Third, the speaker was determined after 
appearing in the narrative or visual format several times during the clip. If there were 
many speakers occurring once throughout the segment, the speaker was coded as 
“Multiple.” Fourth, the format of the video was coded. Lastly, all categories and sub-





categories in the instrument were coded dichotomously, one for presence and zero for 
absence. A paper form was completed for all videos and the data were then entered into 








The Statistical Package for the Social Sciences (SPSS) was used to conduct all 
quantitative data analysis.  
To address the first Aim, to examine the videos with respect to source, speaker, 
format, race/ ethnicity of person with lived experience, number of views, length, date 
uploaded, descriptive statistics, including frequencies and percentages were calculated. 
For each category (and sub-topic) the number and percentage of videos that mentioned 
that item was calculated along with the view count and cumulative view percent.  
A similar analysis was presented for each of the main content categories (in a 
separate table) and for sub-categories (Aim 2). The number of videos uploaded by year 
was portrayed in a line graph, with year on the horizontal axis and number of videos on 
the vertical axis.  
Aim 3 involved examining differences in content covered by source. While there 
were nine source categories, this analysis focused on only two sources, “Television 





80% of the total cumulative views. Differences in the extent to which particular content 
was covered was examined using Chi square analysis.  
Aim 4 will required classifying videos according to number of views. Using view 
count as a classification variable, the videos were grouped into tertiles and a difference in 
the extent to which particular content was covered was examined using Chi square 
analysis. Given the large number of tests conducted, analysis for these Aims 3 and 4 were 
considered exploratory in nature. 
This study was submitted to Institutional Review Board (IRB) at Teachers 






                                                               
                                                               



















YouTube was searched using two key terms, “opiate addiction” and “opioids,” on 
January 18th, 2018. The results for the search term “opiate addiction” were sorted by 
number of views, and the URL, title, and number of views were saved in the Excel 
spreadsheet. The arbitrary cut point for inclusion of a video was a minimum of 1,500 
views. The same process was then repeated with the second key term “opioids.” This 
procedure generated the sample of 371 videos (n = 150 searching with the key term 
“opiate addiction;” n = 221 using key term “opioids”). 
Videos were then screened for the inclusion criteria. A total of 62 videos was 
excluded for various reasons, including not English language (n = 4), discussed only 
heroin (n = 21), involved music videos (n = 2), became unavailable because account was 
closed (n = 5), covered pharmacology education (n = 4); were irrelevant (n = 2) or were 
duplicates (n = 24). The remaining 309 (“opiate addiction,” n = 128; “opioids,” n = 181) 
videos comprised the final sample. The videos varied in their view count from high of 











The first Aim of the Study was to examine the most widely viewed YouTube 
videos on the topic of prescription opiate addiction with respect to source, speaker, 
format, number of views, length, date uploaded.  
The most videos were uploaded in 2017 (N = 148, 47.89%), followed by 2016 
(65, 21.04%), and 2015 (N = 20, 6.47%) (Figure 1). Videos uploaded in year 2017 
(16,435,828 views) and in 2016 (17,362,761 views) shared 33,798,589 views, 
representing 76% of the total views in the study sample. The sample included ten videos 
with more than million views, which were uploaded in 2017 (n = 6), 2016 (n = 3), and 
2014 (n =1).  
 
 . 





The 309 videos varied in their length, with the longest video being 2 hours and 21 
minutes to the shortest video being 15 seconds. The median duration of videos was 6 
minutes and 5 seconds long. The duration of seven out of ten videos with over one 
million views was under 10 minutes long (see Appendix B). 
Table 1 shows frequencies and percentages, total view count, and cumulative 
view count percent for the videos categorized by source of upload, speaker, and format. 
The greatest number of most viewed videos was uploaded by an Internet Based source (n 
= 89, 28.8%) and Television news/Entertainment (n = 83, 26.86%). Videos uploaded 
from these two sources garnered the over 80% of the total cumulative views, 53.57% for 
videos uploaded by Television news/Entertainment (23,943,577 views) and 28.6% for 
videos uploaded by an Internet Based source (12,784,373 views), thus while there was an 
almost equal proportion of videos from these two sources, compared with videos 
uploaded by an Internet Based source, those uploaded by Television news/Entertainment 
had almost twice as many cumulative views. Only nine videos were uploaded by 
Professionals (garnering less than 1% of the total cumulative views, n = 169,934) and 
only 11 videos were uploaded by Government agencies (garnering less than 1 % of total 
cumulative views, n = 343,983). 
The main protagonist, or main speaker, of most videos were Consumers (n = 83, 
26.86%) and garnered 30.35% of cumulative views. Within this category, a person with 
lived experience was most frequent (58, 18.77%), followed by people without lived 
experience but sharing information about opioid misuse and opioid use disorder (21, 





for 71 videos (22.98%). In this category, the Physician/Medical Doctor (n = 35, 11.33%) 
was the most frequent. However, videos with the Professional as a main speaker gathered 
only 3.24 % of cumulative views. Government agency speakers occurred in 10 videos but 
only amassed 0.25% of cumulative views.  
None of the videos featured Celebrity or Professional Athlete as a main 
protagonist to provide information about the topic. While a representative of the 
Television news/Entertainment (11.97%) category was the main speaker only in 37 
videos, these videos garnered 16,857,689 (37.72%) cumulative views, which was the 
most out of all Speaker categories. 
With respect to the format of the videos, there was 51 documentaries 
(representing almost 17% of the total number of videos), however videos with this format 
garnered 31% of the total cumulative views (13,821,848). While views in the format of a 
talk show/discussion panel represented only about eight percent of all videos (n = 25), 
these videos garnered over 25% of the total cumulative views (11,342,859). About one in 
five videos used a format of a news report with anchor, and these videos garnered 17% of 
the total cumulative views (7,756,843). More than 10% of the videos had a “talk by 
professional” format, but these videos garnered less than 2% of the total cumulative 










Table 1. Frequency, Percent, View Count, and Cumulative View Percent by 
Source, Speaker, and Format of 309 YouTube Videos About the Opiate Epidemic, 2018 
 
Upload Source N (%) View Count Cumulative View (%) 
U1. Consumer 46 (14.89%) 2,014,771 4.51% 
U1A. Person with lived experience 24 (7.77%) 1,194,119 2.67% 
U1B. Spouse of the person 
misusing opioids 0 0 0% 
U1C. Parent of the person misusing 
opioids 0 0 0% 
U1D Person w/o lived experience 
knowing personally someone who 
misuses opioids 
2 (0.65%) 302,303 0.68% 
U1E Person w/o lived experience 
sharing information 20 (6.47%) 518,349 1.16% 
U2. Professional videos 9 (2.91%) 169,934 0.38% 
U2A. Physician / Medical Doctor 9 (2.91%) 169,934 0.38% 
U2B. Mental Health/ Addiction 
Professional 0 0 0% 
U2C. Academic 
Professional/Professor 0 0 0% 
U2D. Emergency Room Personnel 0 0 0% 
U2E. Judge/ Sheriff/ Cop 0 0 0% 
U3. Government videos? 11 (3.56%) 343,983 0.77% 
U4. Nongovernmental 
organization 37 (11.97%) 1,816,333 4.06% 
U5. Television news/ 
Entertainment 83 (26.86%) 23,943,577 53.57% 
U6. Treatment Center 18 (5.83%) 1,754,051 3.92% 
U7. Celebrity 0 0 0% 
U8. Internet Based 89 (28.8%) 12,784,373 28.60% 
U9. Other: 16 (5.18%) 1,866,865 4.18% 
Speaker N (%) View Count Cumulative View (%) 






Table 1 continued 




S1A. Person with lived experience 58 (18.77%) 9,287,178 20.78% 
S1B. Spouse of the person 
misusing opioids 1 (0.32%) 2,900 0.0065% 
S1C. Parent of the person misusing 
opioids 2 (0.65%) 17,704 0.04% 
S1D. Person w/o lived experience 
knowing personally someone who 
misuses opioids 
1 (0.32%) 22,819 0.05% 
S1E. Person w/o lived experience 
sharing information 21 (6.8%) 4,235,703 9.48% 
S2. Professional videos 71 (22.98%) 1,449,178 3.24% 
S2A. Physician / Medical Doctor 35 (11.33%) 894,262 2% 
S2B. Mental Health/ Addiction 
Professional 18 (5.83%) 304,006 0.68% 
S2C. Academic 
Professional/Professor 3 (0.98%) 36,146 0.08% 
S2D. Emergency Room Personnel 1 (0.32%) 3,078 0.007% 
S2E. Judge/ Sheriff/ Cop 0 0 0% 
S2F. Other? 14 (4.53%) 211,686 0.47% 
S3. Government organization 10 (0.32%) 111,607 0.25% 
S4. Nongovernmental 
organization 7 (2.27%) 40,982 0.09% 
S5. Television news/ 
entertainment 37 (11.97%) 16,857,698 37.72% 
S6. Treatment Center 2 (0.65%) 12,108 0.03% 
S7. Celebrity 0 0 0% 
S8. Professional Athlete 0 0 0% 
S9. Other 38 (12.3%) 1,911,513 4.27% 
S10. Multiple 61(19.74%) 10,744,497 24% 




F1. Documentary 51 (16.5%) 13,821,848 30.93% 






Table 1 continued 




F3. Talk by professional 31(10.03%) 635,988 1.42% 
F4. Talk show/ Discussion Panel 25 (8.09%) 11,342,859 25.38% 
F5. Animation? 16 (5.18%) 2,714,970 6.07 % 
F6. Still images? 4 (1.29%) 114,171 0.26 % 
F7. News report with anchor 61(19.74%) 7,756,843 17.35 % 
F8. V-Blog 23 (7.44%) 1,168,157 2.61% 
F9. Multiple formats 44(14.24%) 1,635,435 3.66 % 








The second Aim of the Study was to examine the most widely viewed YouTube 
videos on the topics of prescription opiate addiction with respect to content, including 
background information about the opioid epidemic, signs and symptoms of prescription 
opioid misuse; risk factors; first use; populations at risk for misuse; opioid dependency 
withdrawal symptoms; information on opioid use disorder and overdose and its reversal; 
stigma; treatment of opioid use disorder; alternative options for treatment of chronic pain; 
prevention strategies for individuals, providers and communities; information on locating 
treatment or help; consequences; and barriers preventing discontinuation of prescription 
opioid misuse. 
Five of the 18 content topics coded for the Study were included in the majority of 
the videos: “Background of the opioid epidemic” (n = 157), “Risk factors for prescription 





“Treatment for opioid use disorder” (n = 156), and “Consequences of opioid use 
disorder” (n = 221) (Table 2). The videos addressing the latter four topics also had the 
greatest proportion of cumulative views. In terms of proportion of total cumulative views, 
nine of the 18 content categories garnered one-half or more of the total cumulative views 
(these categories were not mutually exclusive).  
The topic that was most likely to be covered and to garner the greatest number of 
total cumulative views was “Information on opioid use disorder and overdose,” which 
was evident in 89.79% of all the videos (n = 250), garnering (40,128,591 views). The 
second most covered topic was the “Risk factors for prescription opioid misuse,” which 
was covered in 241 videos. While almost 78% of the videos addressed this topic, they 
garnered only 66.53% of the cumulative views. In contrast, “Consequences of opioid 
use” was addressed in approximately 72% of the videos, but these videos garnered almost 
82% of the total cumulative views.  
The topics least likely to be covered in the videos were “Alternative options for 
treatment of chronic pain” and “Prevention strategies for individuals.” The former was 
covered in only 41 (13.27%) of the videos, but garnered over 30% of the cumulative 
views. The latter was covered in only 46 (14.89%) of the videos and garnered only 7.14% 
of cumulative views.  Other topics that were covered in less than one of four videos 
included “Population at risk to misuse prescription opioids,” “Reversal of opioid 






Table 2. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Content Categories in 309 YouTube Videos About the Opiate Epidemic,  
2018 
Content N (%) View Count 
Cumulative 
View % 
C1. Background of the opioid 
epidemic 
157 
(50.81%) 22,400,065 50.12 % 
C2. Physical signs and 
symptoms of the misuse 
140 
(45.31%) 27,649,648 61.86 % 
C3. Behavioral signs and 
symptoms of the misuse 
140 
(45.31%) 26,305,929 58.86 % 
C4. Risk factors for prescription 
opioid misuse 
241 
(77.99%) 29,733,506 66.53 % 
C5. First use of prescription 
opioids 
113 
(36.57%) 19,633,124 43.93 % 
C6. Population at risk to misuse 
prescription opioids 66 (21.36%) 19,683,530 44.04 % 
C7. Opioid dependency 
withdrawal syndrome 
141 
(45.63%) 13,413,030 30.01 % 
C8. Information on opioid use 
and overdose 
250 
(80.91%) 40,128,591 89.79 % 
C9. Reversal of opioid overdose 69 (22.33%) 17,075,773 38.21 % 
C10. Stigma 84 (27.1%) 10,908,808 24.41% 
C11. Treatment for opioid use 
disorder 
156 
(50.49%) 28,784,656 64.40 % 
C12. Alternative options for 
treatment of chronic pain 41 (13.27%) 13,472,598 30.14 % 
C13. Prevention strategies for 
providers 63 (20.39%) 14,136,710 31.63% 
C14. Prevention strategies for 
individuals 46 (14.89%) 3,190,032 7.14% 
C15. Prevention strategies for 
communities 
104 
(33.67%) 23,435,686 52.44% 
C16. Information for locating the 
treatment or help 70 (22.65%) 7,017,374 15.7% 
C17. Consequences of opioid use 
disorder 
221 
(71.52%) 36,550,711 81.78% 
C18. Barriers preventing 
discontinuation of misuse/ 
getting to treatment 





Some topics that were not covered by the majority of videos garnered a 
comparatively large amount of cumulative views. For example, while about 45% of the 
videos covered the topics of physical and behavioral signs and symptoms of misuse, these 
videos garnered approximately 60% of cumulative views. Likewise, while only about one 
in five videos covered the topics of “Population at risk to misuse prescription opioids” 
and “Reversal of opioid overdose,” these videos garnered over 44% and just fewer than 
40% of cumulative views, respectively. “Prevention strategies for providers” was covered 
in about one in five videos, but garnered over 30% of cumulative views. The topic of 
“Stigma” was covered in 84 (27.18%) of the videos and garnered almost 25% of the total 
cumulative views. The text below outlines examples of the content covered under each 
main category in greater detail. 
Approximately one-half of the videos covered information about “Background of 
opioid epidemic” (Table 3). “Overprescribing by physicians” was addressed in almost 
one-third of the videos and attracted over 40% of the total cumulative views. All of the 
other sub-categories were covered in less than one of five videos. While there were only 
57 videos that addressed marketing practices of pharmaceutical industry, these videos 
garnered over one-third of the total cumulative views. Slightly more than 15% (n = 47) 
mentioned content related to the notion that since they were “Prescribed by doctors so 
non-addictive/safe to use” and these videos attracted almost 30% of the total cumulative 
views. Another topic for which the cumulative views was much larger than the number of 





Table 3. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Background of Opioid Epidemic in 309 YouTube Videos, 
2018 




C1. Background of opioid 
epidemic 157 (50.81%) 22,400,065 50.12% 
C1A. Overprescribing by 
physicians 97 (31.39 %) 18,546,303 41.50% 
C1B. Pharma Industry 
Practices  57 (18.45 %) 14,972,837 33.50% 
C1C. Pill mills  42 (13.59%) 4,839,308 10.83% 
C1D. Cooperation of FDA and 
Pharma industry 34 (11%) 2,315,969 5.18% 
C1E. Fifth vital sign/Under 
treatment of pain 31 (10.03%) 11,478,286 25.68% 
C1F. Prescribed by doctors so 
non-addictive/safe to use 47 (15.21%) 12,885,288 29.83% 
C1G. High cost of pills on 
black market 43 (13.92%) 3,333,430 7.46% 
C1H. Low cost of heroin in 
comparing to prescription 
opioids on black market 
48 (15.53%) 5,038,243 11.27% 
 
There were only 31 videos (10.03%) that addressed this topic, but these videos garnered 
over 25% of the total cumulative views.  
The topic of “Physical signs and symptoms of prescription opioid misuse” was 
addressed in 45% of the videos (n = 140) and attracted almost 62% of the total 
cumulative views (Table 4). None of the subtopics was widely covered within this 
category. But in some cases, the percent of cumulative views was much greater than the 





Table 4. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Physical Signs and Symptoms of Prescription Opioid 
Misuse in 309 YouTube Videos, 2018 




C2. Physical signs and symptoms 
of prescription opioid misuse 140(45.31%) 27,649,648 61.86% 
C2A. Nodding 32 (10.36%) 18,350,114 41.06% 
C2B. Constipation 23 (7.44%) 10,248,244 22.93% 
C2C. Euphoria 69 (22.33%) 17,612,461 39.41% 
C2D. Tolerance 60 (19.42%) 5,055,489 11.31% 
C2E. Dependence/Taking pills to 
feel “normal”  60 (19.42%) 8,421,615 18.84 % 
C2F. Small pupils 10 (3.24%) 1,422,608 3.18% 
C2G. Sedation  35 (11.33%) 5,321,848 11.91% 
C2H. Itching 7 (2.27 %) 3,292,421 7.37 % 
C2I. Respiratory depression/ slow 
breathing 33 (10.68%) 1,416,503 3.17 % 
C2J. Weight loss 11 (3.56%) 382,969 0.86% 
C2K. Hyperalgesia (increased 
sensitivity to pain)  15 (4.85%) 445,931 0.99% 
C2L. Hard to recognize the 
symptoms 11 (3.56%) 890,648 1.99% 
  
For example, while only 32 videos (10.36%) depicted “Nodding” these videos 
garnered over 40% of the total cumulative views. The topic of “Dependence/Taking pills 
to feel ‘normal’” was mentioned in approximately 20% of the videos and attracted a 
similar proportion of total cumulative views. 
There were 140 videos that mentioned “Behavioral signs and symptoms of 
misuse” and these videos attracted almost 60% of the total cumulative views (Table 5). 





Table 5. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Behavioral Signs and Symptoms of Misuse in 309 
YouTube Videos, 2018 




C3. Behavioral signs and symptoms 
of misuse 140(45.31%) 26,305,929 58.85 % 
C3A. Social withdrawal  20 (6.47%) 1,118,398 2. 5% 
C3B. Mood swings 6 (1.94%) 321,546 0.72% 
C3C. Disinterest in previously liked 
activities 20 (6.47%) 589,759 1.32% 
C3D. Increased irritability 16 (5.18%) 800,428 1.79% 
C3E. Use without the prescription 69 (22.33%) 5,123,550 11.46% 
C3F. Use differently than prescribed 25 (8.09%) 2,004,001 4.48% 
C3G. Overlapping prescriptions 
(doctor shopping) 27 (8.74%) 1,265,412 2.83% 
C3H. Snorting or injecting crushed 
pills 45 (14.56%) 8,843,596 19.79% 
C3I. Lying 25 (8.09%) 4,154,816 9.3% 
U3J. Manipulating 21 (6.8%) 16,186,522 36.22% 
U3K. Sleeping in unusual times 4 (1.29%) 502,643 1.12% 
U3K. Leaving the house in unusual 
times 2 (0.65%) 118,502 0.27% 
U3M. Stealing and pawning 35 (11.33%) 7,769,097 17.38% 
U3N. Family members fighting about 
pills 2 (0.65%) 458,639 1.03% 
  
more than 20% of the videos. While “Use without a prescription” was covered in 69 
videos (22.33%), these videos attracted under 12% of the total cumulative views. 
In contrast, there were only 21 videos (6.8%) addressing the topic of 





“Risk factors for prescription opioid misuse” was a popular topic occurring in 
almost 78% of the videos, which attracted ~ 66% pf the total cumulative views (Table 6). 
Of the 13 sub-categories under this content, the most popular in terms of coverage among 
the videos and percent of total cumulative views was “Legal prescription for chronic  
 
Table 6. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Risk Factors for Prescription Opioid Misuse in 309 
YouTube Videos, 2018 




C4. Risk factors for prescription 
opioid misuse 241(77.99%) 29,733,506 66.53 % 
C4A. Legal prescription for acute 
pain from musculoskeletal 
injury/sport injury/ accident 
142(45.95%) 9,654,779 21.6 % 
C4B. Legal prescription after dental 
work 17 (5.5%) 3,944,065 8.82% 
C4C. Legal prescription post- 
surgery 34 (11%) 11,748,457 26.29% 
C4D. Legal prescription for chronic 
pain 165 (53.4%) 16,248,843 36.36% 
C4E. Mental Illness 24 (7.77%) 3,373,749 7.55% 
C4F. History of substance abuse 27 (8.74%) 1335868 2.89% 
C4G. Low Income 19 (6.15%) 2,188,266 4.9% 
C4H. Living in rural areas 47 (15.21%) 16,113,099 36.05% 
C4I. Daily high doses of prescribed 
medication 55 (17.8%) 3,778,590 8.45% 
C4J. Overlapping opioids and 
benzodiazepine prescription 17 (5.5%) 243,307 0.54% 
C4K. Attending pharm parties 3 (0.98%) 55,079 0.12% 
C4L. Using opioid prescriptions as a 
self-care for women 3 (0.97%) 27,024 0.06% 
C4M. Boredom 5 (1.62%) 11,261,221 25.2% 






Table 6 continued 




C4O. Inability to sleep 5 (1.62%) 165,047 0.37% 
C4P. Using to relax/ relieve anxiety 22 (7.12%) 1,914,661 4.28% 
C4R. Using to get high 61 (19.74%) 9,521,109 21.3% 
C4S. Doctors can’t say no to patient/ 
Doctors unaware of addictive 
properties 
27 (8.74%) 16,620,708 37.19% 
 
pain,” which was covered in 165 videos (53.4%), but these videos garnered only 
approximately 36% of the total cumulative views. “Legal prescription for acute pain from 
musculoskeletal injury/sport injury/ accident” was addressed in almost half of the videos, 
but these garnered only ~22% of the total cumulative views. The large majority of the 
videos did not cover any of the other topics. In two cases, the percent of total cumulative 
views was much greater than the number and percent of the videos addressing the 
respective topic. The first was “Legal prescription-post surgery,” covered in 34 (11%) of 
the videos but garnering over 26% of total cumulative views, and “Living in rural areas,” 
covered in 47 (15.21%) videos, but attracting over 36% of total cumulative views. The 
topic of “Boredom” was mentioned only in 5 videos, but accounted for 25.2% cumulative 
views. None of the other topics were widely covered.  
The main topic concerning “First use of prescription pain analgesics” was 
addressed in almost 37% of the videos (n = 113) and attracted almost 44% of total 
cumulative views (Table 7). “Legal prescription for acute pain from musculoskeletal 





addressed in 52 (16.83%) videos. These videos did attract over 35% of the cumulative 
views.  None of the other topics in this category was widely covered, but some attracted a 
disproportionately high percent of cumulative views. The most extreme example was 
“Taken from a home medicine cabinet,” which was covered in only 17 (5.5%) videos, but 
attracted almost 25% of the total cumulative views. Other examples are “Legal 
prescription post-surgery” and “Legal prescription for chronic pain.” In both of these 
cases, the topic was covered in approximately 10% of the videos, but attracted >25% of 
the cumulative views.  
 
Table 7. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to First Use of Prescription Pain Analgesics in 309 YouTube 
Videos, 2018 




C5.  First use of prescription pain 
analgesics  113(36.57) 19,633,124 43.93% 
C5A. Legal prescription for acute 
pain from musculoskeletal injury/ 
sports injury/ accident 
52 (16.83%) 15,796,482 35.34% 
C5B. Legal prescription after dental 
work 8 (2.59%) 11,329,656 25.35% 
C5C. Legal prescription post- surgery 28 (9.06%) 1,185,290 26.52% 
C5D. Legal prescription for chronic 
pain 34 (11%) 12,620,862 28.24% 
C5E. From a friend 29 (9.39%) 2,753,388 6.16% 
C5F. From a family member 13 (4.21%) 270,573 0.61% 
C5G. Taken from a home medicine 
cabinet 17 (5.5%) 10,508,459 23.51% 






The topic “Population at risk for prescription opioid misuse” was only covered in 
66 videos, but these videos attracted 44% of the cumulative views (Table 8). 
“Adolescents” were the risk group most likely to be delineated. While this group was 
mentioned as being at risk in 41 videos (13.3%), these attracted over 37% of cumulative 
views. Similar discrepancies were observed for “Men,” “Adults 19-25 years old” and 
“Elderly.” Opioid dependency withdrawal symptoms” were covered in almost half of the 
videos, but these videos attracted on ~ 30% of cumulative views (Table 9). The topic of 
“Pain” was addressed in almost 25% of the videos (n = 77), but these videos only 
attracted ~12% of the cumulative views. None of the other sub-topics in this category 
was widely covered or widely viewed.  
 
Table 8. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Populations at Risk for Prescription Opioid Misuse in 309 
YouTube Videos, 2018 




C6. Populations at risk for 
prescription opioid misuse 66 (21.36%) 19,683,530 44% 
C6A. Women 11(3.56%) 11,192,277 25.04% 
C6B. White middle age women 4 (1.29%) 76,981 0.17% 
C6C. Native American  3 (0.009%) 669,822 1.5% 
C6D. Native Alaskan women 5 (1.62%) 366,832 0.82% 
C6E. Adolescents 41 (13.37%) 16,727,148 37.43% 
C6F. Men 2 (0.006%) 9,437,702 21.12% 
C6G. Adults 19-25 years old 18 (5.8%) 13,842,607 30.98% 






Table 9. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Opioid Dependency Withdrawal Symptoms in 309 
YouTube Videos, 2018 




C7. Opioid dependency withdrawal 
symptoms 141(45.63%) 13,413,030 30.01% 
C7A. Cravings 59 (19.09 %) 3,436,057 7.69% 
C7B. Nausea and vomiting 33 (10.68%) 2163743 4.84% 
C7C. Cold and hot flashes 19 (6.15%) 1,598,993 3.58% 
C7D. Anxiety 32 (10.36%) 4,389,133 9.82% 
C7E. Insomnia 8 (2.59%) 2,493,054 5.58% 
C7F. Muscle crams 15 (4.85%) 684,763 1.53% 
C7G. Diarrhea 17 (5.5%) 698,660 1.56% 
C7H. Perspiration 17 (5.5%) 1,179,165 2.64% 
C7I. Lachrymation (watering of eyes) 8 (2.59%) 722,923 1.62% 
C7J. Rhinorrhea (watering of the nose) 15 (4.85%) 1,012,997 2.27% 
C7K. Restlessness 24 (7.77%) 1,698,514 3.8% 
C7L. Kicking Movement 7 (2.27%) 738,557 1.65% 
C7M. Pain 77 (24.92%) 5,331,586 11.93% 
 
As mentioned above, “Information on opioid use disorder and overdose” was the 
most widely covered topic in terms of both frequency of videos and cumulative views 
(Table 10). The most widely covered and viewed topics in this category included “It is 
killing thousands of people each year,” “Diversion-Selling and buying pills on the black 
market,” Shift to heroin,” and “Relapse.” All of these topics were covered in at least 20% 
of the videos. The “Shift to heroin” was the most widely covered sub-topic that attracted 
the greatest number of views (covered in 140 videos, >45%, which garnered almost 73% 






Table 10. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Information on Opioid Use Disorder and Overdose in 309 
YouTube Videos, 2018 




C8. Information on opioid use disorder 
and overdose 250(80.91%) 40,128,591 89.79% 
C8A. Anyone can get addicted 56 (18.12%) 6,098,531 13.65% 
C8B. It is a disease 61 (19.74%) 4,229,461 9.46% 
C8C. It is killing thousands of people 
each year 87 (28.16%) 16,110,878 36.95% 
C8D. High jacked brain 23 (7.44%) 1,242,489 2.78% 
C8E. Opioids are not the first line for 
treating chronic pain 29 (9.39%) 1,843,267 4.12% 
C8F. Taking too many opioids can cause 
breathing depression leading to death 38 (12.3%) 4,109,217 9.19% 
C8G. Addiction involves behavior 
change- compulsion, continuity and 
consequences 
24 (7.77%) 5,013,185 11.22% 
C8H. Opioid use disorder is treatable 49 (15.86%) 2,981,908 6.67% 
C8I. Taking opioids with other drugs 
increase the chance for overdose 29 (9.39%) 3,062,792 6.85% 
C8J. Diversion- Selling and buying pills 
at the black market 76 (24.6%) 10,962,901 24.53% 
C8K. Shift to heroin 140(45.31) 32,562,134 72.86% 
C8L. Shift to fentanyl 60 (19.42%) 9,268,972 20.74% 
C8M. Shift to other drugs: 20 (6.47%) 1,403,250 3.14% 
C8N. Relapse 62 (20.1%) 10,558,972 23.63% 
C8O. Higher risk for overdose for people 
coming out of treatment or prison 12 (3.88%) 618,996 1.38% 
C8P. Harm Reduction Strategies 19 (6.15%) 2,103,607 4.71% 
 
 “Reversal of opioid overdose” was covered in 69 videos (22.33%), but attracted 
almost 40% of cumulative views (Table 11). Information about Naloxone (Narcan) was 
the most widely covered subtopic in terms of inclusion in the videos (17.8%) and 





only mentioned in 22 videos (7.12%), but these videos garnered almost 30% of the 
cumulative views. None of the other subtopics were widely covered or viewed. 
 
Table 11. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Reversal of Opioid Overdose in 309 YouTube Videos, 
2018 




C9. Reversal of opioid overdose 69 (22.33%) 17,075,773 38.21% 
C9A. Information about naloxone 
(Narcan) 55 (17.8%) 15,944,559 35.68% 
C9B. Training on how to use 
Naloxone 5 (1.62%) 817,121 1.8% 
C9C. Good Samaritan Law 4 (1.29%) 1,667,128 3.73% 
C9D. Very high use of Narcan by 
emergency personnel 22 (7.12%) 13,042,958 29.18% 
C9E. Addicts combative when come 
out of overdose 1 (0.32%) 34,914 0.08% 
C9F. Getting people to the treatment 
after overdose 7 (2.27%) 1,329,148 2.97% 
  
“Stigma” was covered in little less than one-third of the videos and attracted 
approximately 25% of the cumulative views (Table 12). None of the subtopics were 
widely covered or widely viewed. “Battling stigma,”” Lack of compassion/empathy,” and 
“Need for a cultural shift on how to view the addiction/addicts” were the most widely 
covered and viewed subtopics, but in all cases, these were included in less that 15% of 







Table 12. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Stigma in 309 YouTube Videos, 2018 




C10. Stigma 84 (27.18%) 10,908,808 24.41% 
C10A. A person being humiliated to 
talk about their problems 15 (4.85%) 3,272,334 7.32% 
C10B. A person being afraid to talk 
about their problems 5 (1.62%) 1,267,034 2.83% 
C10C. Battling stigma (asking to 
normalize addiction/opioid drug 
disorder as a disease) 
43 (13.92%) 3,400,189 7.6% 
C10D. Lack of compassion/ empathy 38 (12.3%) 6,195,218 13.86% 
C10E. Need of cultural shift on how 
to view the addiction/ addicts 
36 (11.65%) 3,801,673 8.5% 
 
Just over fifty percent of all videos mentioned “Treatment for opioid disorder” 
and these videos attracted almost 65% of the cumulative views (Table 13). None of the 
sub-topics in this category was widely covered or widely viewed. “Medication assisted 
therapy with Buprenorphine (Suboxone)” was mentioned in almost 20% of the videos, 
but these videos only attracted slightly more that 5% of the cumulative views. In contrast, 
“Inpatient/Rehab” was also mentioned in ~ 20% of the videos, but these videos garnered 
over 43% of the cumulative views.  
“Alternative options for treatment of chronic pain” was a content category that 
was mentioned in only 41 videos (13.27%), yet these videos garnered over 30% of the 
total cumulative views (Table 14). None of the sub-topics in this category were covered 





were addressed in only 13 videos (<5%), these videos attracted over one quarter of the 
total cumulative views.  
 
Table 13. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Treatment Options for Opioid Disorder in 309 YouTube 
Videos, 2018 




C11. Treatment options for opioid 
disorder 156(50.49%) 28,784,656 64.4% 
C11A. Medication assisted therapy 
with Buprenorphine (Suboxone) 57 (18.45%) 2,382,272 5.3% 
C11B. Medication assisted therapy with 
Naltrexone (Revia, Vivitrol) 23 (7.44%) 1,182,770 2.65% 
C11C.Mediaction assisted therapy with 
Methadone 50 (16.18%) 5,588,030 12.5% 
C11D. Negative reviews on Methadone 
therapy 3 (0.97%) 190,449 0.43% 
C11E. Counseling and behavior 
therapies 26 (8.41%) 1,471,825 3.29% 
C11F. Impatient/ Rehab 64 (20.71%) 19,422,987 43.46% 
C11G. Other: 54 (17.48%) 5,085,785 11.38% 
  
Table 14. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Alternative Options for Treatment of Chronic Pain in 309 
YouTube Videos, 2018 




C12. Alternative options for 
treatment of chronic pain 41 (13.27%) 13,472,598 30.14% 
C12A. Acetaminophen (Tylenol) or 
ibuprofen (Advil) 9 (2.91%) 177,176 0.4% 
C12B. Cognitive behavioral therapy 5 (1.62%) 91,946 0.21% 






Table 14 continued 




C12D. Medications for depression or for 
seizures 7 (2.27%) 463,516 1.04% 
C12E. Interventional therapies 
(injections) 1 (0.32%) 2,600 0.008% 
C12 F. Exercise and weight loss 13 (4.21%) 949,491 2.12% 
C12 G. Other therapies such as 
acupuncture and massage 13 (4.21%) 11,333,514 25.36% 
C12H. Alternative options for chronic 
pain do not work 5 (1.62%) 455,818 1.02% 
 
“Prevention strategies for providers” was addressed in more than 20% of the 
videos (n = 63) and garnered over 30% of the cumulative views (Table 15). None of the 
sub-topics in this category was covered in more than 10% of the videos. However, the 30 
videos addressing the topic of “Improve prescribing practices by using CDC guidelines” 
attracted almost 25% of the cumulative views, and the 27 videos addressing the topic 
“Consider benefits and harms when prescribing opioid therapy for individual patients” 
attracted approximately 25% of the cumulative views. 
“Prevention strategies for individuals” were mentioned in only 46 videos 
(14.89%) and attracted less than 8% of the cumulative views (Table16). None of the sub-
topics in this category was mentioned in more than 5% of the videos or garnered more 







Table 15. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Prevention Strategies for Providers in 309 YouTube 
Videos, 2018 




C13. Prevention strategies for 
providers 63 (20.39%) 14,136,710 31.63% 
C13A. Interactive web-based training 
regarding addiction or other training  12 (3.88%) 494,296 1.11% 
C13B. Improve prescribing by using 
CDC guidelines 30 (9.71%) 10,784,805 24.13% 
C13C. Maximize use of PDMP 
(Prescription drug monitoring program) 24 (7.77%) 1,828,258 4.09% 
C13D. Educate patients on adverse 
effects, storage and disposal 7 (2.27%) 116,376 0.26% 
C13E. Provide the treatment or 







C13F. Consider benefits and harms 
when prescribing opioids therapy for 
individual patients 
27 (8.74%) 12,166,798 27.22% 
 
In contrast, “Prevention strategies for communities” were mentioned in over one-
third of the videos (n = 104) and attracted over 50% of the cumulative views (Table 17). 
None of the five sub-topics in this category were mentioned in more than 20% of the 
videos.  Yet the 21 videos (6.8%) mentioning “Increased access to Naloxone” garnered 
25.71% of cumulative views and the 55 videos (17.8%) mentioning “System and legal 
changes” garnered over 35% of the cumulative views. “Decriminalization of addicts” was 
observed in 12.94% of the videos, but attracted only 7.8% cumulative views.  
“Information on locating treatment or help” was mentioned in 70 videos (22.65%) 





Table 16. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Prevention Strategies for Individuals in 309 YouTube 
Videos, 2018 




C14. Prevention Strategies for 
individuals 46 (14.89%) 3,190,032 7.14% 
C14A. Never take opioids in greater 
amounts or more than prescribed 9 (2.91%) 62,778 0.14% 
C14B. Store and dispose medication 
properly 10 (3.24%) 1,248,761 2.79% 
C14C. Work with your doctor 9 (2.91%) 113,602 0.25% 
C14D. Do not take opioids with alcohol 10 (3.24%) 72,782 0.16% 
C14E. Do not take opioids with 
benzodiazepines, muscle relaxants, 
hypnotics 
2 (0.65%) 39,569 0.089% 
C14F. Know your options for chronic 
pain treatment 4 (1.29%) 470,277 1.05% 
C14G. Do not share or sell your 
medication 
 
5 (1.62%) 87,105 
 
0.19% 
C14H. Seek help/ do not wait till hitting 
the bottom 12 (3.88%) 1,072,274 2.4% 
C14I. Family group therapy 1 (0.32%) 48,998 0.11% 
C14J. Importance of the communication 
in family 12 (3.88%) 19,40,269 4.34% 
 
Only one video mentioned the SAMHSA Service Locator. The main way videos in this 
category identified resources was through a “URL for more information embedded within 
the video” (n = 51).  
“Consequences of opioid use disorder” was one of the most widely covered and 
viewed topics, represented in over 70% of the videos (n = 221) and attracting almost 82% 





Table 17. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Prevention Strategies for Communities in 309 YouTube 
Videos, 2018 




C15. Prevention strategies for 
communities 104(33.66%) 23,435,686 52.44% 
C15A. System and legal changes 55 (17.8%) 15,916,853 35.6% 
C15B. Prevention education in schools  23 (7.44%) 899,512 2.01% 
C15C. Decriminalization of addicts 40 (12.94%) 3,484,159 7.8% 
C15D. Prevention to diminish demand 43 (13.96%) 3,376,072 7.55% 
C15E. Increased access to naloxone 21 (6.8%) 11,491,514 25.71% 
 
Table 18. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Information on Locating Treatment or Help in 309 
YouTube Videos, 2018 




C16. Information on locating 
treatment or help 70 (22.65%) 7,017,374 15.7% 
C16A. National helpline number 2 (0.65%) 106,175 0.24% 
C16B.SAMHSA Service Locator 1 (0.32%) 1,006,221 2.25% 
C16C. URL for more information 
under the video 33 (10.68%) 3,071,675 6.87% 
C16D. URL for more information 
embedded the video 51 (16.5%) 4,948,299 11.07% 
C16E. Phone number/ address for more 
information under the video 13 (4.21%) 965,638 2.16% 
C16F. Phone number/ address for more 
information embedded in the video 24 (7.77%) 498,285 0.9% 
 
The most widely covered and viewed sub-topic in this category was “Overdose 
and death,” mentioned in 175 videos (56.63% and garnering over 60 % all views). In 





percent) of videos addressing the topic. For example, “Loss of job,” “Loss of house,” and 
“Bankruptcy” was mentioned in approximately 5% to 7% of the videos, but attracted 
32%, 24% and 27% of the total views, respectively.  
 
Table 19. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Consequences of Opioid Use Disorder in 309 YouTube 
Videos, 2018 




C17. Consequences of opioid use 
disorder 221(71.52%) 36,550,711 81.78% 
C17A. Loss of job 20 (6.47%) 14,354,299 32.12% 
C17B. Loss of house 17 (5.5%) 10,757,903 24.07% 
C17C. Bankruptcy 20 (6.47%) 12,014,171 26.88% 
C17D. Loss of partner 14 (4.53%) 2,297,260 5.14% 
C17E. Loss of children 27 (8.74%) 3,164,559 7.08% 
C17F. Imprisonment 44 (14.24%) 5,145,916 11.51% 
C17G. Physical Disability 5 (1.62%) 208,812 0.47% 
C17H. Overdose and Deaths 175(56.63%) 26,945,331 60.29% 
C17I. Adverse effects on families 69 (22.33%) 9,389,587 21% 
C17J. Grandparents care taking of 
children of addicted parents 19 (6.15%) 3,455,334 7.73% 
C17K. Neonatal withdrawal 
syndrome 23 (7.44%) 6,194,922 13.86% 
C17L. Increased occurrence of 
hepatitis 12 (3.88%) 673,671 1.51% 
C17M. If they know the 
consequences they would not start 
taking pills 
13 (4.21%) 1,979,452 4.43% 
C17N. Pills destroy lives 54 (17.48%) 15,932,552 35.65% 
C17O. The only relationship that 
mattered was relationship with the 
pills 







Table 20. Frequency, Percent, View Count, and Cumulative View Percent by 
Selected Sub-topics Related to Barriers Preventing Discontinuation of Misuse/Starting 
Addiction Treatment in 309 YouTube Videos, 2018 




C18. Barriers preventing 
discontinuation of misuse/ starting 
addiction treatment  
96 (31.1%) 22,774,799 50.96% 
C18A. Stress 9 (2.91%) 284,750 0.64% 
C18B. Social isolation of caretaking 
work  0 0 0 
C18C. Unemployment 9 (2.91%) 257,421 0.58% 
C18D. Mean to cope with emotional 
pain and traumatic experiences 33 (10.68%) 6,688,639 14.97% 
C18E. Only mean to cope with the 
physical pain 16 (5.18%) 2,771,739 6.2% 
C18F. Inaccessibility to alternative 
chronic pain treatments 4 (1.29%) 9,448,449 21.14% 
C18G. Women targeted by pharma and 
physicians 1 (0.32%) 2,825 6.0063 
C18H. Lack of specified treatments for 
women, pregnant  5 (1.62%) 91,405 0.20 
C18I. Lack of family- centered 
programs/ centers 1 (0.32%) 19,050 0.04% 
C18J.  Shortage of treatment centers 28 (9.06%) 3,562,017 7.97% 
C18K. Lack of affordable health care 20 (6.47%) 86,0813 1.93% 
C18L. Inaccessibility of expensive 
substance abuse treatment 19 (6.15%) 10,290,072 23.02% 
C18M. Low utilization of existing 
treatment centers 1 (0.32%) 19,050 0.04% 
C18N. Lack of transportation to centers 6 (1.94%) 536,888 1.2% 
C18O. Childcare issues 2 (0.65%) 13,548 0.03% 
C18P. Insurance issues 13 (4.21%) 10,289,000 23.02% 
C18R. Potential loss of child custody 3 (0.97%) 111,355 0.25% 
C18S. Incarceration   31 (10.03%) 2,867,659 6.42% 
 
Many “Barriers preventing discontinuation of misuse/starting addiction 
treatment” were examined.  Overall, over 30% of the videos addressed this topic (n = 96) 





examined was widely covered in the sample of videos. But some sub-topics had a 
comparatively large percent of cumulative views relative to the number of videos in 
which they were mentioned such as “Inaccessibility to alternative chronic pain 
treatments” (n = 4, 21.14% of total views), “Inaccessibility of expensive substance abuse 
treatments” (n = 19, 23.02% of total views), and “Insurance issues” (n = 13, 23.02% of 
total views).  
 
 




Given the wide distribution of upload sources, Aim 3 was delimited in scope to 
the two sources that attracted the majority of views. Videos uploaded by Internet Based 
Sources and Television News/Entertainment sources attracted over 80% of the total 
cumulative views. With only one exception, there were no statistically significant 
differences in the proportion of videos uploaded by these two sources with respect to the 
selected content categories that was covered. The one exception was that compared with 
videos uploaded by Television News/Entertainment sources, a significantly greater 
proportion of videos those uploaded by Internet Based covered the topic 
concerning physical signs and symptoms of prescription opioid misuse (33.73% versus 







Table 21. Frequency and Percent of Videos Covering Selected Content Uploaded 
by Internet Based Sources Versus Television News/Entertainment Sources in 172 
















C1. Background of the opioid 
epidemic (n = 102) 54 (60.67%) 48 (57.83%) 0.144 0.705 
C2. Physical signs and symptoms of 
prescription opioid misuse (n = 76) 48 (53.93%) 28 (33.73%) 7.104 0.008 
C3. Behavioral signs and symptoms 
(n = 68) 41 (46.07%) 27 (32.53%) 3.292 0.070 
C4. Risk factors for prescription 
opioid misuse (n = 128) 65 (73.03%) 63 (75.9%) 0.186 0.666 
C5. First use of the prescription 
analgesics (n = 56) 30 (33.71%) 26 (31.33%) 0.1111 0.739 
C6. Population at risk for 
prescription opioid misuse (n = 32) 14 (15.7%) 18 (21.69%) 1.0006 0.316 
C7. Opioid dependency withdrawal 
symptoms (n = 61) 35 (39.33%) 26 (31.33%) 1.201 0.273 
C8. Information on opioid use and 
overdose (n = 141) 74 (83.15%) 67 (80.72%) 0.171 0.680 
C9. Reversal of the opioid overdose 
(n = 43) 23 (25.84%) 20 (24.1%) 0.070 0.792 
C10. Stigma (n = 40) 23 (25.84%) 17 (20.48%) 0.692 0.406 
C11. Treatment for opioid use 
disorder n = 71) 39 (43.82%) 32 (38.55%) 0.491 0.483 
C12. Alternative options for chronic 
pain (n = 16) 8 (8.99%) 8 (9.64%) 0.021 0.883 
C13. Prevention strategies for 
providers (n = 33) 13 (14.61%) 20 (24.1%) 2.494 0.114 
C14.Prevention strategies for 
individual (n = 20) 12 (13.48%) 8 (9.64%) 0.618 0.432 
C15 Prevention strategies for 
communities (n = 68) 32 (35.96%) 36 (43.37%) 0.989 0.32 
C16.Information on locating help (n 
= 18) 12 (13.48%) 6 (7.23%) 1.793 0.181 
C17. Consequences of opioid use 
disorder (n = 128) 
65 (73.03 
%) 63 (75.9%) 0.186 0.666 
C18. Barriers preventing 
discontinuation of the misuse/start 
of the treatment (n = 94) 









In an effort to examine if the videos attracting the most views differed with 
respect to the content that was covered the videos were classified according to tertiles of 
views and differences on the frequency of videos covering specific content was 
examined. Of the 18 topics examined, there were no statistically significant differences 
for 13. Hence there were differences for five of the topics. The greatest differences were 
observed for two content categories, physical signs and symptoms of misuse and 
stigma. In both cases, videos in the lowest tertile of views were less likely to cover the 
content, but there were no linear trends.  
A total of 34 of the 103 videos in the lowest tertile covered physical signs and 
symptoms, while 52 and 54 of the 103 videos in the middle and highest tertile covered 
this topic, respectively (Chi square = 9.508, p = 009). A total of 25 of the 103 videos in 
the lowest tertile covered the topic of stigma, while 39 of the 103 videos in the highest 
tertile covered this topic (Chi square = 9.515, p = 009). The three other significant 
differences (p < .05) were for the topics concerning first use of prescription opioids, 
populations at risk to misuse prescription opioids, and prevention strategies for 
communities. In all cases, compared with videos in the lowest tertile, those in the highest 
tertile were more likely to cover the respective topic. The latter tests should be interpreted 







Table 22. Frequency of Videos Covering Selected Content About the Opiate 









N = 103 
Least 
views 





C1. Background of the opioid 
epidemic (n = 157) 57 52 48 1.58 0.454 
C2. Physical signs and symptoms 
of the misuse (n = 140) 54 52 34 9.508 0.009 
C3. Behavioral signs and 
symptoms of the misuse (n = 140) 52 46 42 1.985 0.371 
C4. Risk factors for prescription 
opioid misuse (n = 241) 72 85 84 5.921 0.052 
C5. First use of prescription 
opioids (n = 113) 47 30 36 6.222 0.045 
C6. Population at risk to misuse 
prescription opioids (n = 66) 31 17 18 7.052 0.029 
C7. Opioid dependency 
withdrawal syndrome (n = 141) 51 50 40 2.896 0.235 
C8. Information on opioid use and 
overdose (n = 250) 87 82 81 1.299 0.522 
C9. Reversal of opioid overdose 
(n = 69) 29 20 20 3.023 0.221 
C10. Stigma (n = 84) 39 20 25 9.515 0.009 
C11. Treatment for opioid use 
disorder (n = 156) 56 55 45 2.874 0.238 
C12. Alternative options for 
treatment of chronic pain (n = 41) 13 11 17 1.575 0.455 
C13. Prevention strategies for 
providers (n = 63) 21 16 26 2.991 0.224 
C14. Prevention strategies for 
individuals (n = 46) 15 12 19 1.89 0.389 
C15. Prevention strategies for 
communities (n = 104) 45 32 27 7.508 0.023 
C16. Information for locating the 
treatment or help (n = 70) 23 21 26 0.702 0.704 
C17. Consequences of opioid use 
disorder (n = 221) 82 70 69 4.898 0.083 
C18. Barriers preventing 
discontinuation of misuse/ getting 
to treatment (n = 96) 













Since developing the proposal for this research, the magnitude and severity of the 
opiate crisis has been recognized to a greater degree. Recently reported data indicate that, 
in 2016, over 11 million people misused prescription opioids (U.S. Department of Health 
and Human Services [HHS], 2018), 116 people died each day from overdoses caused by 
opioids (HHS, 2018), 46 people die each day from overdoses caused by prescription 
opioids (CDC, 2017i), over 2 million people had an opioid disorder (HHS, 2018), almost 
1 million people used heroin, and over 2 million people started using prescription opioids 
(HHS, 2018). The economic costs were estimated to be over 500 billion (White House, 
2017). These data reflect the extent and severity of the epidemic and the need to find 
solutions to reduce the harm caused to individuals, families, communities and the nation.  
One element of a more comprehensive national strategy is increasing awareness among 
the public and specific stakeholders, such as citizens, health care providers, and policy 
makers, about the problem. It is here that the Internet in general and YouTube in 
particular can be very helpful.  
YouTube is an important resource for a variety of reasons. One of the main 





for reaching very large audiences of people. This Study revealed that the videos in the 
sample were viewed over 44 million times. Second, the video format does not require a 
high level of reading literacy and many adults in the U.S. have been shown to have low 
levels of reading literacy (National Center for Educational Statistics, 2003).   
Third, YouTube can be accessed through various technologies that are widely 
available, including mobile phones. Forth, videos can be tailored to specific audiences in 
terms of speakers, language, cultural factors, among other factors. Fifth, the video format 
enables communication about complex topics because videos can be replayed and 
demonstrations can be observed. Sixth, it is possible to provide links to additional 
resources, such as where to find treatment or other kinds of assistance. 
 YouTube has been used extensively as a tool for marketing and advertising.  
Increasingly, YouTube is being used for health education and public health research 
(Paek et al., 2010). A search about YouTube shows that the number of publications is 
growing rapidly. For example, several studies that investigated YouTube videos relevant 
to present study were found. Examples of the topics included alcohol intoxication 
(Primack et al., 2016), alcohol brand preferences (Primack et al., 2015), presence of 
alcohol and tobacco in music videos (Cranwell et al., 2015), e-cigarettes (Huan et al., 
2016), anti-smoking videos (Paek et al., 2010), effects of medication use (Chary et al., 
2014; Hansen et al., 2016; Fixsen and Ridge, 2016), portrayals of marijuana use  
(Cavazos-Rehd et al., 2017), effects and use of Salvia plant (Lange et al., 2010), 
depression (Baquero, 2018), learning resources for pharmacokinetics (Azer, 2014), and 





Despite its undeniable popularity, no published studies describing the 
characteristics and content of YouTube’s videos regarding opioid misuse, opioid use 
disorder or the opioid epidemic were found. Recognizing the significance of this urgent 
public health crisis, this study was intended to be a first step in filling this gap in current 
knowledge by identifying and analyzing the most viewed videos on this topic with 









The videos in this study were viewed almost 45 million times. This shows that 
YouTube is an important media channel for communicating with the public about the 
opioid epidemic. As such, if agencies responsible for reducing the harmful consequences 
of the opiate epidemic do not find ways to produce YouTube videos that attract 




Upload Source and Speaker 
 
 
The two main sources of the most widely viewed YouTube videos regarding 
opioid misuse, opioid use disorder and overdose were Internet Based and Television 





and over 80% of the cumulative views. Compared with Internet-based videos, those 
uploaded by Television news/Entertainment had almost twice as many cumulative views 
(28.60% versus 53.57%). Several very widely viewed videos in these categories 
contributed to this result. These results show the power of the news/entertainment format 
to reach a very large audience.  
This finding is consistent with research on YouTube coverage of vaccines in 
which by far the most widely viewed video was based on a segment of the Jimmy 
Kimmel show (Basch, Basch, Zybert, & Reeves, 2017a). In contrast to studies on topics 
such as diabetic retinopathy (Basch et al., 2016), vaccines (Basch et al., 2017a), and Zika 
virus (Basch et al., 2017b), which reported that a comparatively large proportion of 
widely viewed videos were uploaded by consumers, in this study only ~ 15% of the 
sample garnering less than 5% of the total cumulative views were uploaded by 
consumers. 
While “Consumers” may not have been one of the main sources uploading videos, 
they were often the main speaker (in over 25% of videos that garnered over 30% of total 
cumulative views). A person with lived experience was generally the main speaker of the 
Consumer category. There were an almost equal percentage of videos in which 
consumers and health professionals were the main speaker (26.86% and 22.98%, 
respectively). But the videos portraying consumers as the main speakers garnered almost 
10 times as many cumulative views as those in which professionals were the main 





These findings suggest that one of the best ways to reach consumers will be by 
having the messages delivered by those in the news or entertainment industry or 
consumers themselves. Many viewers may have selected videos in which the speaker is 
someone with whom they can identify. In contrast, as mentioned above, while health 
professionals were the main speaker in almost 25% of the videos, these videos garnered 
only 3.24% of the total cumulative views. This suggests that, if a goal is to attract 
viewers, those conceptualizing and designing videos should not use health professionals 
to deliver the message.  
Government organizations funded with public tax dollars are responsible for 
health promotion and disease prevention in general and with respect to mitigating harm 
caused by the opiate epidemic in particular. The results of this study revealed that 
governmental organizations uploaded 11 videos (< 4%) in the study sample, collectively 
garnering 343,983 views (less than 1% of the total cumulative views). In the 10 videos in 
which a government official was the main speaker, these videos attracted only one-
quarter of 1 % of the total cumulative views. A conclusion from this study is, therefore, 
that these organizations have not found ways to reach a large audience with their 
messages.  
Studies of YouTube on other topics have similarly found that only a small number 
of the most widely viewed YouTube videos were uploaded by governmental agencies 
(Baquero 2017; Basch et al., 2017a; Hansen, 2016; Yiannakoulias, Tooby, & Sturrock, 
2017). This is unfortunate since a major responsibility of such agencies is to educate the 





prevent disease and promote health (Healthy People, 2018). In contrast, there are also 
examples of when governmental agencies have been able to produce YouTube videos 
that are widely viewed (Pandey, Patni, Singh, Sood, & Singh, 2010). To the extent that 
governmental agencies hope to reach large audiences with their messages, it would 
behoove them to invest resources to improve understanding about ways to produce videos 
that will be widely viewed.  
Collectively, these findings combined with the qualitative descriptions of the most 
widely viewed videos suggest that viewers are attracted to a narrative interlaced with a 
real-life story presented by a person with lived experience or a television 
news/entertainment personality.  In contrast, while videos with presentations by 
professionals were included in the sample, they received a very small proportion of the 
total cumulative views. The invitation to the inner worlds of consumers with the lived 
experience describing stories of their first use and the consequences they lived through 
seems to capture the deep essence of despair that this disorder carries and seems to attract 
viewers.  The messages and language used by consumers may contain important 
information for researchers and professionals as well as other consumers (Fixsen & 







There was no dominant format among the widely viewed videos in the sample.  





“Documentary” (~31% of total cumulative views) and “Talk show/Discussion panel” 
(~25% of total cumulative views). In both cases, the percentage of total cumulative views 
was much greater than the percentage of videos. Thus, documentaries and talk 
shows/discussion panels were the most popular in terms of frequency of occurrence, and 
together these formats attracted over 50% of the cumulative views. The “News report” 
was another popular format, attracting upwards of 8 million views (> 17% of total 
cumulative views). The “Talk show/Discussion panel” was the format of only ~ 8% of 
the videos, but videos in this format attracted over 25% of the cumulative views. These 
three formats warrant consideration by those developing videos to reach a large audience. 
However, drawing conclusions from these findings is problematic since the results can be 







Many of the topics coded in this study were covered in a large proportion of the 
videos. For example, the following topics were mentioned in over 50% of the videos and 
garnered over 50% of the cumulative views: “Background of the opioid epidemic,” “Risk 
factors for prescription opioid misuse,” “Treatment for opioid use disorder,” and 
Consequences of opioid use disorder.” The most widely covered topic was “Information 
on opioid use and overdose,” which was addressed in over 80% of the videos and 
garnered the greatest number of cumulative views (> 40 million, almost 90% of the total 





sensational value and disturbing visual effects that were presented. A high level of 
sensational value, has been defined as the “degree to which formal and content audio-
visual features of a televised message elicit sensory, affective and arousal responses” 
(Paek et al., 2010, p. 1089), and has been associated with the larger amount of views.  
The opioid epidemic portrays a case study in how there was a lost opportunity by 
the U.S. Public Health Service to use YouTube to help control the epidemic before it 
reached the current level of urgency. But this did not happen. In contrast, for many years, 
messages to physicians conveyed that prescription opioids were a safe and effective way 
to treat pain and would not lead to addiction. It does not seem coincidental that many 
media channels receive a large proportion of their income from the pharmaceutical 
industry. The recent law suit against Purdue Pharma cost the company 640 million 
dollars, but this is a very small amount considering the two to three billion they earned 
annually through the sale of Oxycodone.  
Some of the stories in the videos included the Drug Enforcement Agency’s efforts 
to close the pill mills that were sending the physically dependent individuals to the black 
market for heroin. Once addicted to prescription opioids, which were either no longer 
available or too costly, heroin became a much more readily available and cheaper option. 
Individuals or family members in the videos repeatedly described use of prescription 
opioids for pain due to injury, accident or chronic pain, and how high doses of such 
medicine contributed to the epidemic in small American towns. 
The shift to heroin is frequently covered in the videos and attracted a large 





Emerging literature suggests that illicitly manufactured fentanyl doubled the number of 
overdose deaths from 2015 to 2016 (Bouvier, Elston, Hadland, Green, & Marshall, 2017; 
CDC, 2017f; Prekupec, Mansky, & Baumann, 2017). Fentanyl can be 50-100 times more 
potent than heroin but appeared less frequently in the videos and attracted much less 
attention as measured by cumulative views. This illustrates a topic that needs greater 
attention. 
Other topics that were not widely covered or viewed included stigma, prevention 
strategies for individuals, and information for locating help. Stigma is an important issue 
in combatting this epidemic because many people see this epidemic and the people 
affected as having a weak moral character versus suffering from a medical problem. This 
may reduce individuals’ willingness to seek information and assistance. Anonymity of 
online sites, therefore, provides an excellent alternative since such sites can be accessed 
without embarrassment. Online media channels can help reduce stigma, and can help 
people realize that they are not alone by portraying the many others that suffer from the 
same condition. These media channels also offer the space for the creation of support 
groups that are not limited by geographical constrains (Fixsen & Ridge, 2017).  
“Alternative options for treatment of chronic pain” would seem to be an important 
topic for those seeking ways to control pain other than opioids. Yet this topic was 
mentioned in less than 15% of the videos. The fact that these 41 videos attracted over 
30% of the cumulative views suggest that it is a topic of interest to consumers and 





Of all the topics examined, “Prevention strategies for individuals” had the lowest 
number of cumulative views (7.14%). “Information for locating treatment or help” was 
also one of the least popular topics, addressed in less than one-quarter of the videos and 
garnering only 15.7% of the cumulative views. Indeed, the SAMSHA Service locator was 
mentioned in only one of the 309 videos. These results suggest that additional work is 
needed to disseminate information about prevention.  
“Treatment options for opioid disorder” was mentioned in more than 50% of all 
videos and attracted almost 65% of the cumulative views. But some of the evidence-
based approaches, namely “Medication assisted therapy with Buprenorphine,” were 
mentioned in less than 20% of the videos and garnered only 5.3% of the cumulative 
views. “Inpatient/ rehabilitation” was also mentioned in about 20% of the videos, but 
these videos garnered almost 45% of the cumulative views, suggesting consumers’ 
interest in this treatment modality.  
Most of the videos did not include harmful information however some did offer 
advice that was not based on recommendations of authoritative health agencies. 
Marijuana was often mentioned under “other” in the category “Treatment options for 
opioid use disorder.” These videos were collectively viewed 322,891 times. There is 
research suggesting an association between legalization of cannabis and short-term 
decreases of opioid related deaths (Livingston, Barnett, Delcher, & Waagenar, 2017), but 
CDC has not recommended this approach to treatment. Another example is a substance 
referred to as Kratom, which was recommended in several videos as a way to treat 





substance. Nevertheless, the videos mentioning this had 206,768 collective views. The 
videos suggesting treatment with Kratom provided recipes and involved drinking tea 
made from Kratom, which could give false assurance of the safety of this substance. 
These examples illustrate that while YouTube videos have promise for educating 
consumers and helping them make informed decisions, given that the video content is not 
curated, there is potential for disseminating inaccurate information resulting in dangerous 
consequences. This finding of dangerous remedies depicted on YouTube has been 









The findings and conclusions from this study must be interpreted considering the 
limitations of the design. At least four main limitations affecting the study include (1) 
cross-sectional design (2) scope of information provided by YouTube, including inability 
to distinguish number of views from number of viewers, location of viewers, or whether 
videos were fully viewed (3) having a single coder determine which videos were included 
and excluded from the sample and then complete the coding and (4) issues related to the 
sample. Each is outlined briefly below. 
The study design was cross-sectional. All videos were extracted at one conceptual 





involving YouTube videos since the number of videos is changing constantly along with 
the views assigned to existing videos. This study, therefore, provides only a snapshot 
about the questions addressed and needs verification through replication. Given that, to 
date, no published studies on this topic were identified, this descriptive work is a 
meaningful first step in understanding the characteristics of the most widely viewed 
videos. 
Only certain kinds of information were available about the videos.  Information 
that can be extracted from YouTube does not enable distinguishing between the number 
of views and number of viewers. The outcome variable was intended to provide an 
estimate of the population reach of each video, ideally reflecting the number of people 
that watched each video. It’s clear that this may provide a biased estimate. This is a 
problem inherent in all studies about YouTube. While it is likely that some of the videos 
have been viewed more than once, it seems reasonable to conclude that the number of 
views provides at least a crude measure of reach. Also, the location of the viewers was 
not identified but it seems reasonable to assume that most were from the U.S. There is no 
way to determine if the videos were fully viewed or the attentiveness of the viewer.  
The study design relied heavily on a single coder to determine which videos were 
included and excluded from the sample and then to complete the coding for videos 
selected into the sample. Steps that were intended to mitigate this concern were having 
the Researcher watch many videos prior to beginning the study and conducting a pilot 
study to demonstrate the intra- and inter-rater reliability of the coding. Additional 





There are several issues related to the sample in the study. The sample of videos 
in the study was small. This was intentional since the intent was to only include videos 
with a large number of views. The cut-point of 1,500 views was arbitrary and if a 
different cut-point was used the results may have been different. The small sample size 
precluded some kinds of analysis since there would not be sufficient statistical power, 
and may have skewed the results. Since there were some videos with a disproportionately 
large number of views, these videos disproportionately influenced the findings. Also, 
there is potential bias in the sample since only two keywords were used when extracting 
the sample and different videos would have been identified using different keywords. 
Despite the intent to capture the most viewed videos on opioid misuse, opioid use 
disorder, and opioid epidemic, it is possible that some YouTube videos with a high 
cumulative number of views were not detected. Prior to conducting the study, pilot work 
was conducted to examine the sample of videos resulting from using different keywords 
and the two-selected yielded the greatest number of non-overlapping videos with the 
greatest number of views. 
Collectively, these study limitations are likely to have influenced the findings.  In 
some cases, they indicate ways that future studies may build on this work. In other cases, 












Health care providers who prescribe medication for pain should be required to 
demonstrate a minimal level of understanding about the opiate epidemic and their role in 
preventing harm. Rigorous training in regard to acute and chronic pain management 
would require that providers incorporate compassion, ability to sensitively communicate 
the options of alternative treatment modalities, lifestyle changes, limits of biomedical 
therapies, and the risk and reality of addiction. The priority assigned to educating future 
physicians about chronic pain appears to be low and training in medical school about 
addiction is minimal (Webster, 2017). In the current study, videos related to “Prevention 
strategies for provider” was covered in one of five videos and received over 14 million 
views (over 30% of cumulative views). This suggests that such videos can be an 
important element of a more comprehensive approach to professional preparation of 
providers addressing pain management. These kinds of videos can address providers’ role 
in creating the opioid epidemic improve understanding about the appropriate role of 
prescription opioids in pain management, and steps that can prevent long-term harm 
caused by prescription opioids. CDC (2017d) provides an online training series for 
providers addressing guidelines for prescribing opioids. Given the magnitude, severity 
and urgency of the opiate epidemic, such training should become required for all primary 
doctors who treat patient suffering from pain.  
Health care providers should be required to screen patients for risk factors prior to 
prescribing medications containing opiates. Studies indicate that people who misuse 
prescription opioids are rarely drug naive (Cicero et al., 2017). Several screening 





appropriate decisions about prescribing opioids. Before opioids are prescribed, patient’s 
history of substance use, including alcoholism, nicotine, stimulants, benzodiazepines or 
other substances, should be known (Cicero et al., 2017). In addition, patient’s history of 
the mental disorders should be known as this can substantially increase risks for 
prescription opioid misuse and overdose (CDC, 2017h). Lack of time and too many 
patients often prevent providers from conducting such screening, and this must be 
addressed through reimbursement policies. 
With the stricter guidelines for opioid prescribing, some patients who can benefit 
from opioid therapy may be left untreated. With screening, drug monitoring, and 
continuing education, health care providers can improve the odds for conducting careful 
evaluations of the benefits and risks for individual patients. The pendulum is returning 
back to opiophobia, where physicians are reluctant to prescribe opioids at all (Webster, 
2017), which is unfortunate for patients who can truly benefit from this highly effective 
class of drugs. The difference between addiction, that involves compulsion and continued 
use despite harmful consequences, as opposed to physical dependence should be clear to 
all physicians in both pre-service and in-service roles. This will help ensure that 
physicians do not to ‘cut off’ the patients that are doing well on their opioid treatment 
program.  
The current school of thought that chronic pain treatment should emphasize 
rehabilitation rather than symptom relief (Webster, 2017) is often not supported by 
insurance coverage. The health insurances readily pay for pharmaceutical treatment, but 





reimbursed (McIver, 2017). If there is honest interest in diminishing opioid use for 
chronic pain, significant changes in coverage for alternative treatments would be an 
important element of a more comprehensive approach.  
Widely viewed videos covered not only the issue of inaccessibility to alternative 
chronic pain treatments, but also revealed barriers of inaccessibility of expensive 
addiction treatment. Policies that help address the cost of addiction treatment, involving 
both medically assisted treatment (MAT) and inpatient treatment, should be part of a 
comprehensive response to the current epidemic. The issue of insurance coverage for 
MAT with Buprenorphine in rural areas is affected by lack of physicians certified to 
prescribe such medication. Patients that have to travel long distances to receive MAT 
treatment often places the patient ‘out the network’ and thereby increases cost to the 
individual to the point where it is unaffordable. Policies supporting the use of 
telemedicine to rural areas warrant consideration.  
Naloxone—a drug that can prevent deaths due to overdose—has been available 
since 1971. But it has taken until 2014 for the Food and Drug Administration to approve 
this drug for use in reversal of drug overdose and allow people without medical training 
to administer this life saving action (Gupta et al., 2016). All U.S. states and D.C. have 
now passed new laws or modified existing laws that simplify access to an auto injector or 
nasal spray (McGinty et al., 2018), which increases the chances of immediate overdose 
reversal.  In 2013, more than 80% of Naloxone use was for heroin overdose, but from 
2009 to 2015 there were twice as many deaths from prescription opioid overdose. Some 





familiarity, and cost (Gupta et al., 2016) and lack of insurance coverage. It is essential 
that in the midst of the opioid crisis, the government should ensure that each community 
should have easy and affordable access to the medication that can save someone’s child, 
parent, or significant other, and that can help significantly alleviate the opioid related 
emergency department visits (Kerensky & Walley, 2017). In April 2018, the Surgeon 
General of the United States advocated for increased availability and use of Naloxone as 
a way to reduce the harmful consequences of the opiate epidemic (Surgeon General, 
2018). 
There is a need for legal safe injection sites to prevent spread of infectious 
diseases such as hepatitis (Soipe et al., 2017) and HIV, as well as prevent or treat 
overdose. The opioid crisis is occurring at a time when there are many controversial harm 
reduction strategies that warrant consideration as strategies to reduce morbidity and 
mortality caused by the epidemic. Al-Tayyib, Koester, and Riggs (2017) suggest that 
those who were hooked on prescription opioids prior to injecting heroin for the first-time 
reported heroin as the first and primary drug injected. These people were also more likely 
to report at least one overdose during past the 12 months. Supervised injection facilities 
are well utilized in Australia, Canada, and in several countries in Europe, but overlooked 
or kept underground in U.S (McGinty et al., 2018). Individuals suffering with opioid use 
disorders could highly benefit from safe use facilities who provide clean needles and 
have staff that oversees their use and can provide immediate help in case of overdose. 
These individuals could also benefit from screening and testing for infectious diseases, 





noteworthy harm reduction strategies such as specialized emergency services, hospitals 
on the wheels, and heroin-assisted treatment, have yielded reductions in overdose 
mortality in European countries (Bouvier et al., 2017). Diffusion of the YouTube videos 
about successes and effectiveness of the harm reduction programs outside the U.S. may 
increase policymakers’ interest in creating laws that legalize evidence-based harm 
reduction programs.  
Even though there has been increasing custody of children by grandparents and a 
child abandoned by a parent due to an opioid use disorder or overdose death is on the 
rise, the current policy protecting kinships is non-existent. Widely-viewed videos in this 
study did not provide information on this critical consequence of the opioid epidemic. 
Changes in financial support for unexpected caregivers should be established along 
without the extensive bureaucracy for qualifying to receive the support. As the harmful 
consequences of opioid epidemic continue to be realized (DuPont, 2017), this neglected 
issue will become unavoidable.  
The category “Barriers preventing discontinuation of the misuse/getting to 
treatment” garnered over 50% of cumulative views. Among the sub-topics attracting 
many views within this category were inaccessibility to alternative chronic pain 
treatments and expensive substance abuse treatment, and insurance issues. Videos 
covering topics such as shortage of treatment centers, lack of affordable healthcare, lack 
of transportation to treatment, incarceration or unemployment were much less viewed, 





for the treatment services and treatment centers for those who are already affected by the 
opioid epidemic are crucial.  
The above matters were also indirectly expressed in YouTube videos discussing 
need for system and legal changes in the category “Prevention strategies for 
communities.” System and legal changes appeared only in 17.8% of all videos, but 
garnered 35.6% of views. The needed changes often included ideas of trans-sectoral 
cooperation where legislators, state and federal governments, physicians, academics, and 
the public worked together to improve prevention, treatment, and eradication of the 
opioid epidemic (DuPont, 2017). YouTube videos present a venue that could be part of a 








YouTube’s popularity, convenience, immense amount of video uploads per 
minute, and continuous improvement (Azer, 2014) underscores its potential as a 
meaningful tool for health educators. Successful utilization of this tool to deliver 
increased awareness and interest about this (and other) health issues has important 
implications for health education practice.  
Video education has many benefits over traditional education as it is more 
efficient, convenient, and supports individualized learning. Pilieci, Salim, Heffernan, 





skill demonstration in providing medical students with knowledge. The results of the 
present study demonstrate that videos uploaded by professionals were not widely viewed. 
Health educators need to gain additional training on how to create videos that are widely 
viewed. This needs to be done through ongoing collaboration with those who create 
highly viewed videos (White et al., 2016) and who understand how to present content so 
it becomes attractive to the viewer. In the world of social media, some believe that 
“content is a king” (White et al., 2016, p. 703), and so it is indispensable for health 
educators to gain additional tools on how to deliver key messages effectively through 
video. This has not been one of the skills traditionally emphasized in health education 
training (National Commission for Health Education Credential, 2018).  
The death rate due to opioid overdose among older adolescents, ages 15-19, more 
than doubled since 1999 (Curtin, Tejada-Vera, & Warner, 2017). The 2015 Monitoring 
The Future survey revealed a 2.9% prevalence of non-medical opioid use for youth aged 
12–13 years and 9.4% for youth aged 16–17 years. This survey also showed that that 
roughly one third of older adolescents (aged 18 years) with non-medical prescription 
opioid use continued such use in the future (Osborne, Serdarvic, Crooke, Striley, & 
Cottler, 2017). Since a physician prescribes them, many of adolescents are under the false 
assumption that prescription opioids are safer than illicit drugs (Foggers & McGuiness, 
2014). About 37% of videos in this study did point out that adolescents were a population 
at risk for the misuse. An important step to reduce adolescents’ risk for opioid addiction 
is to incorporate education into health education curriculum. No evidence-based 





Educators must keep up with the most current information in regard to the opiate 
epidemic.  In this study, the shift to heroin is frequently covered and has attracted a large 
proportion of the cumulative views (72%). Emerging literature, however, suggests that 
illicitly manufactured fentanyl, deadlier than heroin, increased since 2013 and doubled 
the number of overdose deaths from 2015 to 2016 (Bouvier et al., 2017; Kerensky & 
Walley, 2017; Prekupec et al., 2017, CDC, 2017f). Videos in the present study 
mentioning fentanyl garnered only 20% of cumulative views. To provide effective 
prevention, educators need to know most recent sources of harm that are connected to the 
opioid problem. 
In addition to prevention in schools, continuing education for health educators and 
health care providers is needed to help them understand the opiate epidemic and ways 
education can help prevent its harmful effects (Finnell, Twilman, Breslan, Schultz, & 
Miller, 2017). Professional preparation programs should enable primary care physicians, 
emergency department doctors and other experts to effectively deliver education on how 
to store, dispose, and take opioids. Is has been shown that techniques such as 
Motivational Interviewing can reduce prescription opioid overdose risk behaviors, 
including opioid misuse or overdose (Bohnert, Cunningham, Greenwald, Thomas, & 
Chermack, 2016; Coffin et al., 2017). YouTube videos would be an effective method to 
present role playing between the doctor and patient on appropriate use of motivational 
interviewing where opioid misuse is suspected.  
Due to initially hard-to-recognize symptoms of opioid misuse, there is a need to 





where consumers or family members of people suffering opioid use disorder shared their 
first-hand experiences and warnings about signs and symptoms. However, many 
important signs and symptoms that would help family members to recognize the problem 
more easily and earlier were not mentioned in most widely viewed videos. These include 
social withdrawal, mood swings, disinterest in previously liked activities, increased 
irritability, weight loss, small pupils, overlapping prescriptions with benzodiazepines, 
unusual sleeping patterns or use of medications differently than prescribed. Given that 
many people search for information on YouTube, this knowledge could be essential and 
should be incorporated into future videos.  
It is common that many reversed overdoses are not followed by summoning 
professional help. People witnessing or helping to reverse the overdose are often 
discouraged from calling for help due to fear of legal penalties (Kerensky & Walley, 
2017). Thus, efforts to diminish opioid related overdoses require education on Samaritan 
laws that protects the person who calls for professional help from criminal charges.  
A few of the most widely viewed videos addressed the alarming increase in the 
number of children witnessing parental use, overdoses, or death. These children may 
experience difficult situations involving police or emergency personnel in their homes at 
night or over the weekend so they are unable to participate in the regular school day 
activities. The principal of one elementary school addressed this problem by taking 
initiative in getting clean clothes or extra food for these children. While the budget cuts at 
this school did not allow the presence of the full-time guidance counselor, she asked the 





afternoon playing in the gym or reading. The aim was to provide the children with an 
adult figure that they could count on in the short term as many lost this sense of security 
from their parents. It would be progressive if such initiatives would be shaped in other 
schools in areas that have been greatly affected by the opioid epidemic.  
Health educators should become trained in administering Naloxone and become 
certified to train others. CDC (2016) guidelines recommend considering Naloxone and 
overdose education for patients or family members of patients with the history of 
substance abuse, overdose, or with a high opioid dosage (Kerensky & Walley, 2017). 
Because familiarity with its use may be low (Gupta et al., 2016), health educators should 
become trained so they can provide further instructions and training to members of their 
communities 
Chronic pain plays a large role in the opioid epidemic. In the present study, the 
fact that opioids are not the first line of the treatment for chronic pain was rarely 
mentioned in the most viewed videos. This information is essential as many alternative 
options of treatment of chronic pain may work better and have fewer risks and side 
effects (CDC, 2017e). Increasing awareness about alternative options for effectively 
treating chronic pain is needed. These alternatives include individually tailored physical 
activity, physical therapy, weight loss, massage, meditation, or acupuncture (CDC, 
2017e; Wojcikowsky, Vigar, & Oliver, 2018). 
Anonymity of online sites means less embarrassment and more ability to link with 
the people who suffer the same conditions (Fixsen & Ridge, 2017). Stigma was presented 





addressing stigma were generally focused on normalizing opioid drug disorder as a 
disease. Stigma surrounding prescription opioid misuse, opioid use disorder, and 
overdoses seems inevitable and it can be one of the major reasons why individuals would 
seek information on YouTube and other Internet sites. Additional efforts are needed to 
reduce stigma associated with this problem. This will involve shifting beliefs of those 
who see the root of the problem as a moral issue and a failing of a person’s character 
versus a medical and public health problem that can be treated.  
There is a need to improve education about the effectiveness of medication and 
counseling. The CDC, Substance Abuse and Mental Health Services Administration, 
Institute of Medicine, and World Health Organization all support medication-assisted 
treatment of opioid use disorder (Olsen & Sharfstein, 2014). While many widely viewed 
videos mentioned treatment of opioid use disorder in the form of in-patient treatment, it is 
interesting that not many offered information on medically assisted treatment with 
buprenorphine or naltrexone. Similarly, portraying opioid addiction as a treatable medical 
disease versus a moral weakness was not mentioned frequently. YouTube videos should 
be the space to disseminate information on treatment that prolongs life, leads to recovery, 
and lowers the risk of relapse, and thereby addresses these kinds of topics (Olsen & 
Sharfstein, 2014; D’Onofrio et al. 2015; Weiss et al., 2015; Potter et al., 2017).  
A large body of research indicates that people exiting in-patient treatment or 
returning from incarceration are at heightened risk of overdose (Binswanger & Gordon, 
2016; Bukten et al., 2017; DuPont, 2017; Friedmann Wilson, Hoskinson, Poshkus, & 





consumption of the same amount of the drug taken prior to incarceration or treatment can 
be deadly. This important fact received only 1.38 % of the cumulative views of widely 
viewed videos. Increasing awareness about the danger of overdose after completing 
treatment/prison time has to be disseminated not only to the people who suffered from 
opioid use disorder, but to their families as well. Recovery is not easy or fast and families 
must be aware that addiction is an ongoing health threat for years, even lifetimes 








At the outset of this study (in 2017), about 900 results on PubMed were obtained 
with the search word “YouTube.” This shows that YouTube related research is in its 
initial stages. Millions of views of YouTube’s videos offer evidence that YouTube can be 
an effective tool for sharing health information. This study confirms some previous 
findings that professionals and governmental agencies have not developed YouTube 
videos that are among those that are most widely viewed. Further research is, therefore, 
needed to improve understanding about how to design videos that are acceptable and 
viewed by the intended target populations.  
One way to acquire this kind of information would be qualitative research about 
the kinds of content and other characteristics of videos that attract a large number of 





aspect of research. This study revealed that in four of five “Television 
news/entertainment” videos garnering over million views the protagonist described the 
problem of the opioid crisis with the use of sarcasm and humor. Paek et al. (2010) also 
found that among 87 antismoking video clips on YouTube, 21.8% contained some kind 
of humor. As social media are becoming more and more important for communicating 
health issues, using humor as a communication strategy warrants consideration (Lee, 
Slater & Tchernev, 2015). The effective use of language in health campaigns thus needs 
further investigation so it can be incorporated in health promotion YouTube videos in 
ways that not only attract viewers, but that are also able to communicate messages 
effectively.  
The present study did not collect any data about how the videos made the viewers 
feel.  Many videos seemed to attain sensational value and included disturbing visual 
effects, which has been associated attracting views (Paek, Kim, & Hove, 2010). Future 
studies can build on this research to improve understanding about the kinds of emotional 
appeals that attract viewers and are effective in communicating useful information and 
influencing action. 
The present study did not include analysis of the comments posted in response to 
the videos. Investigations of comments posted under the videos might provide insight 
into the quality, use and potential effects of the videos (Kerber et al., 2012). Such 
research could document features that are praised versus disliked, which, in turn warrants 





A challenge for YouTube dissemination research is that there are very limited 
existing studies that have assessed the use and effects of the videos (Kerber et al., 2012). 
Developing more effective means of evaluating the effect of the knowledge 
dissemination about the opioid epidemic is needed. Such research could narrow down 
which types of videos have the best potential to affect viewers’ attitudes, beliefs and 
behaviors.  
Information shared on YouTube can be misleading or be presented with the intent 
to market particular products (Pitcher, Newton, & Amendola, 2017). Pitcher et al. (2017) 
suggested that viewers are often not drawn to videos of high quality. This may be due, in 
part, because it might be difficult for consumers to determine the competency of those 
delivering the message and the accuracy of the message content. In some cases, what 
constitutes accurate content may be controversial. In the present study, the videos offered 
predominantly accurate information. However, as mentioned above there was some 
concern about videos that mentioned using marijuana and Kratom in the context of 
“Treatment options for opioid use disorder.” There does not appear to be any effort by 
health agencies to monitor the veracity or potentially harmful information being 
disseminated on YouTube, but such monitoring seems needed. 
Research on health-related YouTube videos is at an early stage of development.  
The first studies indexed in the National Library of Medicine were published in 2007, and 
the number has been growing since that time.  There are various ways of conducting this 
research and new methods are needed to determine which approaches are most useful for 





The current study used a cross-sectional design and most of the studies reviewed 
also used this approach. This is a major limitation since the videos on YouTube and the 
viewership profiles are changing constantly. Prospective studies are needed to improve 
understanding about the antecedents to the popularity of videos. This kind of study would 
enable assessment of the social and political context and how this might affect the 
trajectory of views.  
The dynamic characteristics of YouTube present barriers that complicate the 
application of the research methods (Paek et al., 2010). In the present study, it’s likely 
that not all of the relevant videos were captured. And, even if they were, new videos are 
being uploaded every day. The high number of views support that YouTube videos can 
be an effective tool for the dissemination of health-related information. Researchers need 
to improve the rigor and standardization of methods in ways that accommodate 
YouTube’s “mobile, fluid and interactive features” (Paek et al., 2010, p. 1098).  
Agencies concerned with health promotion and disease prevention are concerned 
with the quality and accuracy of the information on YouTube (Madathil, Rivera-
Rodriguez, Greenstein, & Gramopadhye, 2015). Government agencies, including CDC, 
uploaded a total of 11 videos in the study’s sample and garnered 0.77% of cumulative 
views. Professionals uploaded 9% and gained 0.38% of cumulative views. Both 
governmental agencies and professionals have evidence-based information for 
individuals who are looking for help, but they have to find better ways of sharing this 
content. Too many people view YouTube each day to be overlooked as a potential tool 





most viewed YouTube videos offers an opportunity to acquire knowledge about how to 








The millions of views attracted by the videos in the study sample suggests that 
people are interested in this issue, that they may be looking for help or answers, and that 
they are turning to YouTube as a source of information. Improving understanding about 
ways to create videos that convey accurate and up-to-date information and at the same 
time attract a large number of viewers should be a priority to increase awareness and 
interest about this urgent crisis.  
Because of its popularity, low cost and easy access, YouTube should become a 
common tool used by governmental agencies and non-governmental organizations to 
educate consumers. Given that a substantial proportion of Americans have low levels of 
literacy and are oriented to video communications, YouTube represents an important 
opportunity for health promotion and disease prevention regarding the opiate epidemic. 
Training professionals to create high quality videos and cooperation with creative 
videographers should be a priority. 
When initiating this study, I was convinced that opioids should not be prescribed 
to anyone but those suffering from cancer or in hospice care. I realize now that they can 





physical dependency and addiction as well as careful screening when prescribing opioids 
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DESCRIPTIVE ANALYSIS A OF THE MOST VIEWED 
 
YOUTUBE VIDEOS RELATED TO OPIOID EPIDEMIC 
Andrea Randolph-Krisova, Principal Investigator  
Teachers College, Columbia University  
 
 
Coder number: _ _                              Date Coded: _ _ / _ _ / _ _  
 
 
Video Number: _ _ _                          Length of Video: _______ 
 
 
Number of views: _ _ ,_ _ _ ,_ _ _ ,_ _ _ 
 
 




U1. Consumers 1=Yes   0-No 
U1A. Person with lived experience 1=Yes   0=No 
U1B. Spouse of the person misusing prescription opioids 1=Yes   0=No 
U1C. Parent of the person misusing prescription opioids 1=Yes   0=No 
U1D. Person without lived experience but sharing information 
based on knowing someone personally with prescription opioid 
misuse? 
    1=Yes  0=No 
U1E. Person without lived experience sharing information 
about prescription opioid misuse 1=Yes    0=No 
U2. Professional videos 1=Yes    0=No 
U2A. Physician / Medical Doctor 1=Yes   0=No 
U2B. Mental health/ Addiction professional 1=Yes   0=No 








Coding manual (continued) 
UPLOADED BY  
U2D. Emergency room personnel 1=Yes   0=No 
U2E. Judge/ Sheriff/ Cop 1= Yes  0=No 
U2F. Other: 1= Yes   0=No 
U3. Government agency videos 1=Yes   0=No 
U4. Nongovernmental organization 1=Yes   0=No 
U5. Television news/ entertainment 1=Yes   0=No 
U6. Treatment center 1=Yes   0=No 
U7. Celebrity 1=Yes   0=No 
U8. Internet Based 1=Yes   0=No 
U9. Other: 1=Yes   0=No 
SPEAKER 
S1. Consumers 1=Yes   0=No 
S1A. Person with lived experience 1=Yes   0=No 
S1B. Spouse of the person misusing prescription opioids 1=Yes   0=No 
S1C. Parent of the person misusing prescription opioids 1=Yes   0=No 
S1D. Person without lived experience but sharing information 
based on knowing someone personally with prescription opioid 
misuse 
1= Yes   0=No 
S1E. Person without lived experience sharing information about 
prescription opioid misuse 1= Yes   0=No 
S2. Professional videos 1=Yes   0=No 
S2A. Physician / Medical Doctor 1=Yes   0=No 
S2B. Mental Health/ Addiction professional 1=Yes   0=No 
S2C. Academic Professional/Professor 1=Yes   0=No 
S2D. Emergency Room Personnel  1=Yes   0=No 
S2E. Judge/ Sheriff/ Cop 1=Yes   0=No 
S2F.  Other  1=Yes   0=No 
S3. Government agency videos 1=Yes   0=No 
S4. Nongovernmental organization 1=Yes   0=No 
S5. Television news/ entertainment 1=Yes   0=No 
S6. Treatment center 1=Yes   0=No 
S7. Celebrity 1=Yes   0=No 
S8. Professional Athlete: 1=Yes   0=No 





Coding manual (continued) 
FORMAT  
F1. Documentary 1=Yes   0=No 
F2. Interview ( one person and interviewer) 1=Yes   0=No 
F3. Talk by professional 1=Yes   0=No 
F4. Talk show/ Discussion Panel with the host (several 
people) 1=Yes   0=No 
F5. Animation 1=Yes   0=No 
F6. Still Images 1=Yes   0=No 
F7. News report with anchor 1=Yes   0=No 
F8. V-Blog 1= Yes   0=No 
F9. Multiple Formats:  1=Yes   0=No 
F10. Other:  1=Yes    0=No 
CONTENT 
C1. Background of the opioid epidemic 1=Yes   0=No 
C1A. Overprescribing by physicians 1=Yes   0=No 
C1B. Pharma industry practices (marketing, opioid samples, 
trips for doctors, visits) 1=Yes   0=No 
C1C. Pill mill clinics (dirty doctors and pharmacies) 1=Yes   0=No 
C1D. Cooperation of FDA and Pharmaceutical companies 1=Yes   0=No 
C1E. Pain fifth vital sign- under-treatment of pain 1=Yes   0=No 
C1F. Prescribed by the doctor so it is safe to take/ non-addictive 1=Yes   0=No 
C1G. High cost of pills on black market 1=Yes   0=No 
C1H.  Low cost of heroin in comparing to prescription pills on 
black market 1= Yes   0=No 
C2. Physical signs and symptoms of misuse 1=Yes   0=No 
C2A. Nodding 1=Yes   0=No 
C2B. Sleepiness/ drowsiness  1=Yes   0=No 
C2C. Euphoria 1=Yes   0=No 
C2D. Tolerance 1=Yes   0=No 
C2E. Dependence / Taking pills to feel “normal” 1=Yes   0=No 
C2F. Small pupils 1=Yes   0=No 
C2G. Sedation 1=Yes   0=No 
C2H. Itching 1=Yes   0=No 
C2I. Respiratory depression / slow breathing 1=Yes   0=No 
C2J. Weight loss 1=Yes   0=No 





Coding manual (continued) 
CONTENT  
C2L. Hard to recognize the signs and symptoms     1=Yes   0=No 
C3. Behavioral signs and symptoms of misuse     1=Yes   0=No 
C3A. Social withdrawal 1=Yes   0=No 
C3B. Mood swings 1=Yes   0=No 
C3C. Disinterest in previously liked activities 1=Yes   0=No 
C3D. Increased irritability 1=Yes   0=No 
C3E. Use without the prescription 1=Yes   0=No 
C3F. Use differently ( in higher doses or more frequently) as 
prescribed 1=Yes   0=No 
C3G. Overlapping prescriptions ( doctor shopping) 1=Yes   0=No 
 C3H. Snorting or injecting pills 1=Yes   0=No 
 C3I. Lying 1=Yes   0=No 
 C3J. Manipulating 1=Yes   0=No 
 C3K. Sleeping in unusual times 1=Yes   0=No 
 C3L. Leaving the house in unusual times 1=Yes   0=No 
 C3M. Stealing and pawning 1=Yes   0=N0 
 C3N. Family members arguing about pills 1=Yes   0=N0 
C4. Risk factors for prescription opioid misuse 1=Yes   0=No 
C4 A. Legal prescription for acute pain from Musculoskeletal 
injury/ Sports Injury/ Accident 1 =Yes   0=No 
C4 B. Legal prescription for dental problems 1=Yes   0=No 
C4 C. Legal prescription after surgery 1=Yes   0=No 
C4 D. Legal prescription for chronic pain 1=Yes   0=No 
C4 E. Mental illness 1=Yes   0=No 
C4 F. History of substance abuse 1=Yes   0=No 
C4 G. Low income  1=Yes   0=No 
C4 H. Living in rural area 1=Yes   0=No 
C4 I. Daily high doses of prescribed medication  1=Yes   0=No 
C4 J. Overlapping pain reliever and benzodiazepine 
prescription 1=Yes   0=No 
C4 K. Attending pharm parties 1=Yes   0=No 
C4L. Using pain prescription medicine as a self-care by women 1=Yes   0=No 
C4M. Boredom 1=Yes   0=No 
C4N. Preadolescents sexual- abuse 1=Yes   0=No 





Coding manual (continued) 
CONTENT  
C4P. To relax/ relieve anxiety   1=Yes   0=No 
C4R. To get high   1=Yes   0=No 
C4S. Doctors can’t say no to prescribe/ Doctors unaware of 
addictive properties  1=Yes   0=No 
C5. First use of prescription pain analgesics of video  1=Yes    0=No 
C5A. Legal prescription for acute pain from Musculoskeletal 
injury/ Sports Injury/ Accident 1=Yes   0=No 
C5B. Legal prescription for Dental problems 1=Yes   0=No 
C5C. Legal prescription after Surgery 1=Yes   0=No 
C5D. Legal prescription for Chronic pain 1=Yes   0=No 
C5E. From a friend 1=Yes   0=No 
C5F. From a family member 1= Yes  0=No 
C5G. Taken from a home medicine cabinet 1= Yes   0=No 
C5H. At the party 1=Yes    0= No 
C6. Population at risk of prescription opioids misuse 1=Yes   0=No 
C6A. Women  1=Yes   0=No 
C6B. White middle- aged women 1=Yes   0=No 
C6C. Native American women  1= Yes  0=No 
C6D. Alaskan Native women  1= Yes   0=No 
C6E. Adolescents  1=Yes    0= No 
C6F. Men 1= Yes   0=No 
C6G. Adults 19-25 years old 1=Yes    0= No 
C6H. Elderly  1= Yes   0=No 
C7. Opioid dependency withdrawal symptoms 1=Yes    0= No 
C7A. Craving 1=Yes   0=No 
C7B. Nausea and vomiting 1= Yes  0=No 
C7C. Cold and hot flashes 1= Yes   0=No 
C7D. Anxiety 1=Yes    0= No 
C7E. Insomnia 1= Yes   0=No 
 C7F. Muscle cramps 1=Yes    0= No 
C7G. Diarrhea 1= Yes   0=No 
C7H. Perspiration 1= Yes   0=No 
 C7I. Lachrymation (watering of eyes) 1=Yes    0= No 





Coding manual (continued) 
CONTENT  
C7K. Restlessness  1= Yes   0=No 
C7L. Kicking movement  1=Yes    0=No 
C7M. Pain 1=Yes    0=No 
C8 Information on opioid use disorder and overdose 1=Yes    0= No 
C8A. Anyone can get addicted 1= Yes   0=No 
C8B. It is a Disease  1=Yes    0= No 
C8C. It is killing thousands of people each year/  1= Yes   0=No 
C8D. High jacked brain 1=Yes    0= No 
C8E. Opioids are not the first line for treating chronic pain 1=Yes   0=No 
C8F. Taking too many opioids can cause breathing depression 
leading to death 1= Yes   0=No 
C8G. Addiction involves behavior change- compulsion, 
continuity and consequences 1= Yes   0=No 
C8H. Opioid use disorder is treatable 1=Yes    0= No 
C8I. Taking opioids with other drugs increase the chance for 
overdose 1= Yes   0=No 
C8J. Diversion- Selling or buying pills at the black market 1=Yes    0= No 
C8K. Shift to heroin 1= Yes   0=No 
C8L. Shift to fentanyl 1= Yes   0=No 
C8M. Shift to other drugs:  1=Yes    0= No 
C8N. Relapse 1= Yes   0=No 
C8O. Higher risk for overdose for people coming out of 
treatment or prisoners 1= Yes   0=No 
C8P. Harm Reduction strategies 1= Yes   0=No 
C9. Reversal of opioid overdose 1=Yes   0=No 
C9A. Information about Naloxone 1=Yes   0=No 
C9B. Training on how to use Naloxone 1=Yes   0=No 
C9C.  Good Samaritan Law 1=Yes   0=No 
C9D. Very high use of Narcan by emergency personnel 1=Yes   0=No 
C9E. Addicts combative when come out of overdose 1=Yes   0=No 
C9F. Getting people to the treatment after overdose 1=Yes   0=No 
C10. Stigma 1=Yes    0=No 
C10A. A person being humiliated to talk about their problems 1=Yes   0=No 
C10B. A person being afraid to talk about their problems 1=Yes   0=No 
C10C. Battling stigma (asking to normalize addiction/ opioid 





Coding manual (continued) 
CONTENT  
C10D. Lack of compassion/ empathy    1=Yes   0=No 
C10E. Need of cultural shift on how to view the addiction/ 
addicts    1=Yes   0=No 
C11. Treatment options for opioid use disorder 1=Yes   0=No 
C11A. Medication assisted therapy with Buprenorphine 
(Suboxone) 1=Yes   0=No 
C11B. Medication assisted therapy with Naltrexone ( Revia, 
Vivitrol) 1=Yes   0=No 
C11C. Medication assisted therapy with Methadone 1=Yes   0=No 
C11D. Negative reviews on Methadone therapy 1=Yes   0=No 
C11E. Counseling and behavioral therapies 1=Yes   0=No 
C11F. Inpatient / Rehab 1=Yes   0=No 
C11G. Other: 1=Yes   0=No 
C12. Alternative options for treatment of chronic pain 1=No    0=No 
C12A. Acetaminophen (Tylenol®) or ibuprofen (Advil®) 1=Yes   0=No 
C12B. Cognitive behavioral therapy  1=Yes   0=No 
C12C. Physical therapy 1=Yes   0=No 
C12D. Medications for depression or for seizures 1=Yes   0=No 
C12E. Interventional therapies (injections) 1=Yes   0=No 
C12F. Exercise and weight loss 1=Yes   0=No 
C12G. Other therapies such as acupuncture and massage 1=Yes   0=No 
C12H. Alternative options for chronic pain do not work 1=Yes   0=No 
C13. Prevention Strategies for providers 1=Yes   0=No 
C13A. Interactive web- based training regarding addiction or 
other training 1=Yes   0=No 
C13B. Improve prescribing by using CDC guidelines 1=Yes   0=No 
C13C. Maximize use of  PDMP( Prescription drug monitoring 
program) 1=Yes   0=No 
C13D. Educate patients on adverse effects, storage and disposal 1=Yes   0=No 
C13E. Provide the treatment or recommend the treatment 1=Yes   0=No 
C13F. Consider benefits and harms when prescribing opioids 
therapy for individual patient 1=Yes   0=No 
C14. Prevention Strategies for individuals 1=No    0=No 
C14A. Never take opioids in greater amounts or more often 
than prescribed 1=Yes   0=No 
C14B. Store and dispose medication properly 1=Yes   0=No 





Coding manual (continued) 
CONTENT  
C14D. Do not take opioids with alcohol    1=Yes   0=No 
C14E. Do not take opioids with benzodiazepines, muscle 
relaxants, hypnotics    1=Yes   0=No 
C14F. Know your options for chronic pain treatment 1=Yes   0=No 
C14G. Do not share or sell your medication 1=Yes   0=No 
C14H. Seek help/ do not wait till hitting the bottom 1=Yes   0=No 
C14I. Family group therapy 1=Yes   0=No 
C14J. Importance of the communication in family 1=Yes   0=No 
C15. Prevention Strategies for communities 1=Yes   0=No 
C15A. System and legal changes  1=Yes   0=No 
C15B. Prevention education in schools 1=Yes   0=No 
C15C. Decriminalization of addicts 1=Yes   0=No 
C15D. Prevention to diminish demand 1=Yes   0=No 
C15E. Increased access to Naloxone 1=Yes   0=No 
C16. Information on locating the treatment or help 1=Yes   0=No 
C16A. National helpline number 1=Yes   0=No 
C16B. SAMHSA Services Locator 1=Yes   0=No 
C16C. URL for more information under the video 1=Yes   0=No 
C16D. URL for more information embedded in the video 1=Yes   0=No 
C16E. Phone number/ address for more information under the 
video 1=Yes   0=No 
C16F. Phone number/ address for more information embedded 
in the video 1= Yes   0=No 
C17. Consequences of opioid use disorder 1=Yes   0=No 
C17A. Loss of job 1=Yes   0=No 
C17B. Loss of house 1=Yes   0=No 
C17C. Bankruptcy 1=Yes   0=No 
C17D. Loss of partner/ marriage 1=Yes   0=No 
C17 E. Loss of children 1=Yes   0=No 
C17 F. Imprisonment 1=Yes   0=No 
C17G. Physical Disability 1=Yes   0=No 
C17H. Overdose or Death  1=Yes   0=No 
C17 I. Adverse effects on families 1=Yes   0=No 
C17 J. Grandparents care taking of children of addicted parents 1= Yes   0=No 





Coding manual (continued) 
CONTENT  
C17L. Increased occurrence of hepatitis     1=Yes   0=No 
C17M. If they knew the consequences they would never start 
taking pills    1=Yes   0=No 
C17N. Pills destroy lives 1=Yes   0=No 
C17O. The only relationship that was mattered was relationship 
with the pills 1=Yes   0=No 
C18. Barriers preventing discontinuation of the misuse/ or 
start addiction treatment 1=Yes   0=No 
C18A. Stress  1=Yes   0=No 
C18B. Social isolation of caretaking work  1=Yes   0=No 
C18C. Unemployment 1=Yes   0=No 
C18D. Mean to cope with emotional pain and traumatic 
experiences 1=Yes   0=No 
C18E. Only mean to cope with the physical pain 1=Yes   0=No 
C18F. Inaccessibility to alternative chronic pain treatments 1=Yes   0=No 
C18G. Women targeted by pharma and physicians 1=Yes   0=No 
C18H. Lack of specified treatments for women, pregnant  1=Yes   0=No 
C18I. Lack of family- centered programs/ centers 1=Yes   0=No 
C18J.  Shortage of treatment centers 1=Yes   0=No 
C18K. Lack of affordable health care 1=Yes   0=No 
C18L. Inaccessibility of expensive substance abuse treatment 1=Yes   0=No 
C18M. Low utilization of existing treatment centers 1=Yes   0=No 
C18N. Lack of transportation to centers 1=Yes   0=No 
C18O. Childcare issues 1=Yes   0=No 
C18P. Insurance issues 1=Yes   0=No 
C18R. Potential loss of child custody 1=Yes   0=No 
C18S. Incarceration   1=Yes   0=No 
 









                                                        Appendix B 
Videos with over million views, length (in minutes) and year of upload 
 
Number of Views Length in minutes Year of Upload 
9,427,956 19:22 2016 
3,572,788 3:13 2014 
3,001,508 5:37 2016 
2,454,654 4:08 2017 
1,640,178 1:52 2017 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
